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ABSTRACT 
Eric M. Kallin 
Epigenetic regulation of gene transcription: Jhdm1b characterization  
and genome-wide localization of H2A ubiquitylation 
 
(Under the direction of Dr. Yi Zhang) 
 
Histone methylation and ubiquitylation play important roles in regulating gene 
expression and form part of the epigenetic memory system that regulates cellular fate.  Two 
general classes of enzymes linked to covalent modification are the JmjC domain-containing 
proteins capable of histone demethylation and the E3 ubiquitin ligases.  Here we report the 
evolutionary conservation of JmjC domain-containing proteins with the goal of predicting 
active demethylases.  We demonstrate that one of these proteins, Jhdm1b, is an H3K36 
demethylase both in vitro and in vivo.  Knock-down of Jhdm1b in primary MEFs inhibits cell 
proliferation and induces cellular senescence in a pRb and p53 pathway-dependent manner 
that is mediated through direct de-repression of p15Ink4b.  Jhdm1b binds to the p15Ink4b 
promoter and maintains low levels of local H3K36me2.  Importantly, knock-down followed 
by rescue experiments demonstrate that this function is mediated through an active JmjC 
domain.  
Transcriptional regulation by PcG proteins is achieved at least partly through the 
PRC1-mediated ubiquitylation of histone H2A (uH2A).  Bmi1 has been demonstrated to be 
critical for H2A ubiquitylation.  Although recent studies have revealed the genome-wide 
binding patterns of some of the PRC1 components there have been no reports describing 
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genome-wide localization of uH2A.  Using the recently developed ChIP-Seq technology, 
here we report genome wide localization of the Bmi1-dependent uH2A mark in MEF cells.  
Gene promoter averaging analysis indicates a peak of uH2A just inside the transcription start 
site (TSS) of well annotated genes that is enriched at promoters containing H3K27me3.  Peak 
finding reveals regions of local uH2A enrichment throughout the mouse genome, including 
almost 700 gene promoters.  Genes with promoter peaks of uH2A exhibit lower level 
expression when compared to genes that do not contain promoter peaks of uH2A.  We 
demonstrate that genes with uH2A peaks have increased expression upon Bmi1 knockout and 
local enrichment of uH2A is not limited to regions containing the H3K27me3 mark.  Our 
work not only reveals Bmi1-dependent H2A ubiquitylation but also suggests that uH2A 
targeting in differentiated cells may employ a different mechanism from that in ES cells. 
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Chapter 1 
Introduction 
Epigenetics is defined as the stable and heritable control of gene expression without 
regards to primary DNA sequence.  This control is brought about by several broad classes of 
events which can alter chromatin structure on a local or global scale.  These alterations in 
chromatin structure include the remodeling of local chromatin through ATP-dependent 
nucleosome repositioning, the incorporation of histone variants into the nucleosome core 
particle, and the covalent modification of DNA or histones.  It is becoming increasingly clear 
that the combination of these epigenetic events at genomic loci have a profound effect on 
gene transcription and overall cellular physiology (summarized in (Berger, Kouzarides et al. 
2009). 
THE BEGINNINGS OF A FIELD 
Well over one hundred years ago, Frederick Miescher was the first to describe the 
DNA/protein complexes which were housed within the nucleus of salmon sperm.  Decades 
before the role of chromosomes in propagating genetic information was recognized, 
biochemists began purifying and characterizing the small basic protein component 
(protamine) of what Miescher named nuclein.  A German biochemist, Albrecht Kossel, 
expanded upon Miescher’s preliminary discovery and isolated a similar material from 
chicken blood.  He noticed that the basic proteins associated with the biological acids were 
distinct from Miescher’s protamine and named the protein histone.  Over the course of the 
next fifty years, extensive characterization of these DNA associated proteins was undertaken 
with a primary focus on purification procedures and comparison between organisms and cell 
types.  The major reason for these early studies was quite simple.  Namely, the proteins were 
so abundant in available cellular preparations that enough starting material could be obtained 
for the biochemical methods available at the time.  Given the ease of sample preparation, 
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researchers began using the DNA associated proteins to hone techniques utilized to 
understand the fundamentals of protein chemistry and biology en masse (Various 1971).   
Throughout these early studies, biochemists believed that the protein found tightly 
bound to DNA was homogenous.  It was not until 1950 that it was shown that this was in fact 
untrue and the widely studied protein preparations were heterogeneous mixtures (Stedman 
1950).  This original work separated histones into two groups which consisted of the lysine 
rich and arginine rich histones and today we know these pools as histone H1 and histone 
H3/H4, respectively (Kornberg and Lorch 1999).  This finding ignited activity in the field to 
focus on potential variation between histone pools among diverse organisms and cell types, 
for scientists believed that histone variation throughout cellular lineages could explain the 
drastic differences in cellular physiology present in multicellular organisms.  However, this 
explosion of research resulted in conflicting findings that have since been attributed to 
protein degradation, fraction heterogeneity, and protein aggregate formation (Various 1971).  
We now understand that the five main classes of histone proteins, H1, H2A, H2B, H3, and 
H4, demonstrate striking conservation throughout evolution.  However, Stedman and 
Stedman’s prediction of the importance of histone proteins on cellular identity and 
multicellular organism development lies at the very heart of the field of epigenetics to this 
day. 
CHROMATIN AND THE CENTRAL DOGMA 
Given a number of reports that provided circumstantial evidence regarding nuclear 
localization of the genetic factors, researchers focused attention on this sub-cellular 
compartment.  This burst of investigation led to the accumulation of evidence which 
prompted Francis Crick to sketch out his Central Dogma in 1958.  In his work, he clearly 
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stated that the decoding of genetic information was directional and processive with the 
majority of information flowing from DNA, through an RNA intermediate, into protein 
(Crick 1970).  The remainder of this section will focus on early work in histone biology and 
biochemistry and how this fit into the Central Dogma.   
Crick’s seminal work in molecular biology paid tribute to almost forty years of 
scientific discovery which spanned from the work of Morgan and colleagues with Drosophila 
genetics to the derivation of DNA macromolecular structure and the purification of the 
enzymes capable of DNA replication and RNA polymerization.  As all of these studies began 
falling into place, the histone biochemists remained hard at work characterizing their 
abundant protein which was intimately linked with the genetic information.  Among the 
groups characterizing the properties of histone was that of Stedman and Stedman.  Their 
work was a direct result of advances in biochemical techniques which allowed for a higher 
resolution separation of extracted histones coupled to powerful assays that allowed for the 
quantification of the relative abundance of key amino acids within these fractions.  Using this 
technique they separated histone preparations into two pools which they named the arginine 
rich and lysine rich fractions, a characterization which stimulated many pioneers in the field 
of histone biochemistry to focus on histone fraction heterogeneity throughout diverse 
organisms and cell types.  Interestingly, it is now clear that histones are remarkably 
conserved throughout eukaryotic life and while these studies may be viewed as distracting, 
the derivation of separation techniques and reconstitution experiments represent fundamental 
advances that still firmly reside in the experimental arsenal of biochemists to this day. 
Between the years of 1960 and 1961 two additional pieces of the Central Dogma 
puzzle were put into place.  First, the purification of DNA dependent RNA polymerase was 
4 
described (reviewed in  (Hurwitz 2005)).  Second, the biological intermediate molecule 
which connected DNA to protein synthesis was proven to be mRNA (Brenner, Jacob et al. 
1961) retiring the one gene one ribosome model of molecular biology for good.  Histones had 
long been known to inhibit a wide range of enzymatic activities in vitro.  However, the 
purification of RNAP along with a sensitive method to detect polymerase activity provided 
the histone biochemist with the tools necessary to prove the long standing hypothesis that 
histones acted as gene repressors.  Seminal work from Huang and Bonner described a 
method whereby chromatin could be reconstituted in vitro from its component histones and 
DNA.  The authors discussed the use of DNA melting curve analysis in monitoring the 
reconstitution experiment and this method which employs step-wise salt dilution is still in 
use to this day (Huang and Bonner 1962).  When chromatin which had been reconstituted 
with purified pea embryo histones was used in the in vitro RNAP assay, researchers found 
that it significantly repressed RNA synthesis (Huang and Bonner 1962).  Trypsin is very 
efficient at cleaving arginine and lysine peptide bonds, two amino acids that are prevalent in 
histones.  This fact armed researchers with the tools necessary to confirm in vitro results 
within a cellular system.  Specifically, incubation of cells with trypsin resulted in the 
degradation of histones in vivo and led to a significant increase in RNA synthesis (Allfrey, 
Littau et al. 1963).    
Advances in biochemical techniques which allowed for the automated identification 
of protein amino acid composition came about in 1958 (Moore, Spackman et al. 1958) and 
were quickly put to work on histone extracts from a diverse range of cell types.  In addition 
to confirming the heterogeneity of original histone preparations, they also revealed 
absorbance peaks which could not be attributed to the standard amino acids (Rasmussen, 
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Murray et al. 1962).  Through comparison of histone fractions with proteins containing post-
translationally modified lysines, a small fraction of both methyl-lysine and acetyl-lysine 
residues were found within the histone polypeptides (Phillips 1963; Murray 1964).  
Importantly, chromatin reconstituted with acetyl-lysine histones could not inhibit RNA 
synthesis in vitro (Allfrey, Faulkner et al. 1964).  The authors comment in this work, 
The findings introduce the possibility that histone effects on nuclear RNA 
metabolism may involve more than a simple inhibition of RNA synthesis, and 
that more subtle mechanisms may exist which permit both inhibition and 
reactivation of RNA production at different loci along the chromosome 
(Allfrey, Faulkner et al. 1964). 
 
Even though the presence of modified lysine residues had been detected, it took an additional 
five years for experiments to show that the methylation of histone H4 was site specific in 
vivo.  Careful fractionation and analysis of tryptic peptides allowed DeLange and colleagues 
to deduce the complete amino acid sequence of H4 including methyl-lysine at position 20 
(H4K20) (DeLange, Fambrough et al. 1969).  This work was followed up by the complete 
sequence of histone H3 which included the specific methylated lysines at position 9 and 27 
(H3K9 and H3K27, respectively) (DeLange, Hooper et al. 1973) and the identification of H3 
methylated at lysine 4 (H3K4) (Honda, Dixon et al. 1975).  
Further studies focused on the post-translational modification of the histone proteins 
have revealed amino acid phosphorylation (Ord and Stocken 1966), sumoylation (Paik and 
Kim 1970; Shiio and Eisenman 2003), glycosylation and ADP-ribosylation (Levy-Wilson 
1983), as well as arginine methylation (Paik and Kim 1970).  Perhaps the most striking 
histone modification based on size and projected effect on overall histone topology is the 
addition of a single molecule of ubiquitin to histones H2A and H2B  (Various 1988).  
Ubiquitin is a 76 amino acid protein present in all eukaryotic cells which was originally 
6 
identified based on its ability to stimulate lymphocyte differentiation in vitro (Goldstein, 
Scheid et al. 1975).  Since this initial characterization, the protein has been found covalently 
linked to numerous cellular proteins in both monomeric and oligomeric forms.  While 
oligomeric addition of ubiquitin to polypeptides is involved in targeting the protein for 
degradation (Ciechanover 1994), the monomeric addition has been implicated in numerous 
functional outcomes (Hicke 2001).  The first identified instance of ubiquitin conjugation was 
the isopeptide linkage of a single ubiquitin molecule to histone H2A at lysine 119 
(Goldknopf and Busch 1977).  Three years later mono-ubiquitynation of histone H2B was 
described (West and Bonner 1980) and its positional addition to lysine 120 was identified 
several years later (Thorne, Sautiere et al. 1987). 
In addition to the identification of modified lysines, the amino acid sequence studies 
described above established secondary structure predictions of the individual histones based 
on similarities to known globular proteins.  Researchers noticed that only the carboxy-
terminal portion of histones H3 and H4 had properties reminiscent of globular proteins and 
while the central portion of histones H2A and H2B had globular characteristics, their termini 
did not (Various 1971).  This hypothesis has since been validated using tryptic digest 
(Weintraub and Van Lente 1974), and more convincingly, crystallographic techniques 
(Luger, Mader et al. 1997).  Interestingly, all of the modified amino acids discussed to this 
point are located within the unstructured regions of the histones.  However, the biological 
function of histone methylation and the effect the site-specific mark had over DNA 
dependent processes was not fully realized for many years to come (see below). 
CHROMATIN STRUCTURE 
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If the 1960s fueled an explosion of research into the heterogeneity of histone fractions 
from the decades prior, the most remarkable advances in the fledgling field of epigenetics 
and chromatin biology of the 1970s were focused on structure-function relationships between 
chromatin and cellular enzymology.  In 1974, the first electron micrographs of intact 
chromatin revealed a 10 nm fiber that was termed “particles on a string” by the authors 
(Olins and Olins 1974).  This was promptly recoined as “beads on a string” later this same 
year when the elegant biochemical analyses of Roger Kornberg and colleagues were 
published.  This work described the oligomeric nature of histone particles as containing two 
copies each of the four core histones (Kornberg and Thomas 1974) and the repetitive nature 
of histone oligomer association with DNA (Kornberg 1974).  The effect of histone H1 on this 
structure was described a few years later (Thoma and Koller 1977) when researchers 
visualized chromatin in the presence and absence of the linker histone and found that H1 
incorporation resulted in a 30 nm fiber.  Single crystal x-ray diffraction of the histone core 
particle at 3.3 Å confirmed its octameric status (Burlingame, Love et al. 1985) and higher 
resolution structural analysis of the nucleosome, defined as the histone core particle 
associated with DNA, revealed the superhelical association of 146 base pairs wrapped around 
the octamer core (Luger, Mader et al. 1997). 
Thus far, this introduction has focused on the foundation of the field of chromatin 
modification and epigenetic regulation of gene transcription.  By the mid-1990’s, scientists 
had amassed enough circumstantial evidence to accurately predict that alterations of local 
chromatin structure could have profound effects on gene transcription.  Furthermore, the 
implication of this control on cellular differentiation and cancer were well recognized.  It was 
clear that the nucleosome represented the repeating unit of chromatin, and specific amino 
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acids located along the unstructured region within histone polypeptides were subject to post-
translational modification.  Finally, a clear link had been described between histone tail 
acetylation and active gene transcription.  However, the enzymes responsible for the in vivo 
modification of histone tails, as well as the role of other histone modifications in 
transcriptional control remained largely undetermined. 
MODERN CHROMATIN BIOLOGY 
The discoveries of the first histone acetyltransferase (HAT) (Brownell and Allis 
1995) and histone deacetylase (HDAC) (Taunton, Hassig et al. 1996) capable of directly 
acting on histone tails welcomed a new age in the functional characterization of chromatin 
and the modifications it harbors.  Since these initial discoveries, the enzymes responsible for 
catalyzing both the addition and removal of identified histone modifications have been 
purified.  In many cases, genetic disruption of these enzymes has revealed the functional 
implication of a given histone tail modification.  Given that the scope of this work is focused 
primarily on histone lysine methylation and ubiquitylation, only these modifications will be 
discussed in detail in the following section.  For more information regarding histone 
acetylation, arginine methylation, phosphorylation, sumoylation and glycosylation the author 
would like to direct the reader to several in depth reviews and the references contained 
therein (Wysocka, Allis et al. 2006; Oki, Aihara et al. 2007). 
Histone lysine methylation 
As discussed in previous sections, several histone lysine residues can be methylated 
including K4, K9, K27, K36, and K79 of H3 and K20 of H4 (Martin and Zhang 2005).  Each 
of these sites is located within the unstructured amino terminal tail of the histones with the 
exception of H3K79 which is located within the globular domain (Feng, Wang et al. 2002).  
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To complicate the issue further, a particular lysine residue can accept one, two, and three 
individual methyl groups.  A variety of genetic and biochemical techniques have been used 
to correlate methylated lysine residues to transcriptional competence.  The first example of 
this was the demonstration that H3K4me in Tetrahymena and yeast was associated with 
actively transcribed macronuclei and acetylated histones, respectively (Strahl, Ohba et al. 
1999).  Additional methyl marks associated with gene activation include H3K79me and 
H3K36me.  H3K9me was demonstrated to be essential for eukaryotic heterochromatin 
formation (Bannister, Zegerman et al. 2001) and thus correlated to gene repression.  In 
addition, H3K27me and H4K20me have also been implicated in gene silencing (Martin and 
Zhang 2005).   
The first enzyme capable of histone methyltransferase activity to be purified was the 
H3K9 specific HMT, SUV39H1, which was found to be the mammalian homolog of fission 
yeast Clr4 and Drosophila suppressor of position effect variegation Su(var)3-9 (Rea, 
Eisenhaber et al. 2000).  Importantly, the active site of this enzyme was mapped to the 
Su(var)-E(Z)-Trithorax (SET) domain which is evolutionarily conserved throughout all 
eukaryotes and is present in multiple proteins in individual species (Dillon, Zhang et al. 
2005).  In addition to SUV39H1, at least 15 additional mammalian HMTs have been 
identified (Martin and Zhang 2005) with activity directed against various lysine residues and 
the variable capacity to methylate to all three states.  These additional enzymes include the 
mammalian homolog of yeast Set2 (Strahl, Grant et al. 2002), Setd2 (Sun, Wei et al. 2005), a 
H3K36 specific HMT and Ezh2, a H3K27 specific HMT (Cao, Wang et al. 2002).  Of all the 
lysine HMTs identified, all possess the SET domain with the exception of Dot1l, an H3K79 
specific HMT conserved from yeast to human (Feng, Wang et al. 2002). 
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In addition to the general correlations presented above, HMT identification has led to 
further insight into the functional role that histone modifications play throughout the life-
cycle of a cell.  For example, fission yeast protein Set2 has been found to associate with the 
phosphorylated form of elongating RNA Polymerase II (polII) (Morris, Shibata et al. 2005).  
This association leads to the enrichment of the H3K36me mark within the coding regions of 
expressed genes (Rao, Shibata et al. 2005) and plays an important role in suppressing polII 
transcription from cryptic start sites (Li, Gogol et al. 2007; Li, Jackson et al. 2009).  While 
these findings in yeast have yet to be extrapolated to mammalian systems, localization of the 
H3K36me mark in higher eukaryotes has revealed a similar enrichment of the modification 
within the transcribed region of expressed genes (Bell, Wirbelauer et al. 2007; Mikkelsen, Ku 
et al. 2007).   
The first example of active removal of methyl groups from histone tail lysine residues 
came from the purification and characterization of the Lysine Specific Demethylase 1 
(LSD1) (Shi, Lan et al. 2004).  This enzyme has been found to remove methyl marks from 
H3K4 and H3K9 through an oxidative mechanism which utilizes a flavin cofactor (Forneris, 
Binda et al. 2005).  Characterization of LSD1 has led to the discovery of the role H3K9me 
plays in inducible gene silencing.  Specifically, the enzyme is recruited to Androgen 
Receptor (AR) target genes where the removal of repressive H3K9me is necessary for the 
efficient induction of gene expression (Metzger, Wissmann et al. 2005). 
As discussed above, the diversity and scope of histone methylation is vast and the 
discovery of LSD1 raised two additional questions regarding the turn-over of histone 
methylation.  First, the chemistry fueling the oxidative reaction could only be applied to 
mono- and di-methylated lysine residues.  Second, phylogenetic analysis could only identify 
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one additional paralogue in mammalian cells.  These two enzymes could not account for 
active removal of methyl groups from all sites of histone modification (Culhane and Cole 
2007).  These two facts prompted researchers to continue biochemical screens for enzymes 
capable of active histone demethylation and a H3K36 specific demethylase, Jumonji 
containing Histone Demethylase 1 (Jhdm1), was identified (Tsukada, Fang et al. 2006).  
Enzymatic activity was mapped to the Jumonji C (JmjC) domain and was shown to adhere to 
a two-step hydroxylation reaction which utilized Fe(II) and α-ketoglutarate as cofactors 
(Klose, Kallin et al. 2006).  Similar to the SET domain family of HMTs, numerous 
mammalian proteins contained a JmjC domain and it was recognized that this protein super-
family could contain demethylases specific for additional histone residues.  To date, JmjC 
domain-containing demethylases have been identified that are capable of removing 
H3K4me1/2/3, H3K9me2/3, H3K27me2/3, and H3K36me1/2/3 ((Klose, Yamane et al. 2006; 
Agger, Cloos et al. 2007; Iwase, Lan et al. 2007; Klose, Yan et al. 2007; Yamane, Tateishi et 
al. 2007)).  Characterization of these enzymes has revealed their role, as well as the role of 
the methylations they erase, in cellular processes which include embryonic stem cell 
pluripotency, X chromosome inactivation (XCI), and hormone receptor signaling pathways 
(reviewed in (Takeuchi, Watanabe et al. 2006; Benevolenskaya 2007; Swigut and Wysocka 
2007)). 
Histone Ubiquitylation 
Experimental evidence suggests that the addition of ubiquitin to lysine 119 of H2A 
and lysine 120 of H2B result in very different functional outcomes.  The majority of these 
findings rely on the isolation and characterization of the enzymes required for the placement 
and removal of the ubiquitin mark.  The first enzyme identified as responsible for histone 
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ubiquitylation was budding yeast protein Rad6, a uH2B specific ligase that had previously 
been linked to DNA repair (Robzyk, Recht et al. 2000).  Genetic manipulation of Rad6 
activity confirmed a general association of the uH2B mark with active chromatin (Davie and 
Murphy 1990) and revealed that Rad6-dependent ubiquitylation of H2B was necessary for 
the enrichment of H3K79me and H3K4me, two additional histone marks intimately linked to 
active gene expression (Lee, Shukla et al. 2007).  Since this initial discovery, an elegant 
biochemical approach has revealed that uH2B allosterically stimulates Dot1 activity to 
methylate H3K79 (McGinty, Kim et al. 2008). 
uH2A has been historically linked to gene expression based on classic two-
dimensional separation studies which demonstrated that it co-migrated with several actively 
transcribed loci on native gels (Barsoum and Varshavsky 1985).  In light of these early 
studies it is surprising that the first identified enzyme capable of placing this mark, Ring1b, 
was a component of the Polycomb repressive Complex 1 (PRC1), which has been implicated 
in the establishment and maintenance of gene repression (Wang, Wang et al. 2004) (see 
below).  Additional evidence for a role of uH2A in gene silencing has stemmed from the 
identification of 2A-HUB, another H2A targeted ubiquitin ligase, and the characterization of 
four separate H2A specific deubiquitylases (reviewed in (Zhou, Wang et al. 2009)). 
Polycomb-mediated gene repression 
An emerging paradigm in epigenetic regulation of cellular physiology is represented 
by the opposing effects of Polycomb Group (PcG) and Trithorax Group (trxG) proteins in the 
maintenance of homeotic transcription factor (Hox) gene transcription during Drosophila 
development (Ringrose and Paro 2004).  The spatial and temporal expression pattern of Hox 
genes is controlled through silencing by PcG and activation by trxG.  Originally identified 
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through classic fly genetics, molecular biology and modern chromatin enzymology have 
linked these genes to factors involved in directly altering local chromatin structure and have 
proven them conserved in higher eukaryotes (Cao and Zhang 2004).   These studies have 
associated many of the trxG group genes to transcription permissible chromatin 
modifications such as histone acetylation and H3K4me.  Alternatively, PcG genes have been 
implicated in catalyzing histone H3K27me and uH2A as described in detail below.   
Arguably the greatest advance in the study of PcG mediated gene repression has been 
the biochemical purification of two protein complexes, PRC1 and PRC2, with distinct 
chromatin modifying capabilities.  The study of these complexes, and the individual 
components they harbor, has led to unprecedented understanding of eukaryotic gene 
repression and facultative heterochromatin formation.  The catalytic core of the human PRC1 
complex is composed of RING1A, RING1B, BMI1, and HPH2 (Wang, Wang et al. 2004) 
and has been extensively studied.  In vitro reconstitution experiments and in vivo loss of 
function studies have demonstrated that Ring1b is responsible for the vast majority of uH2A 
in cells.  Furthermore, both Ring1a and Bmi1can stimulate the ligase activity of Ring1b in 
vitro and in vivo.  Disruption of any of these proteins in vivo leads to the targeted loss of 
uH2A and aberrant HOX gene expression (Cao, Tsukada et al. 2005; Buchwald, van der 
Stoop et al. 2006).  Interestingly, mammalian cells contain at least three Bmi1 paralogues 
which have been shown to substitute for the protein in PRC1 under various cellular contexts 
(Elderkin, Maertens et al. 2007; Wu, Gong et al. 2008).  The mammalian PRC2 complex, 
whose catalytic core is comprised of Ezh2, Suz12, Eed, Aebp2, and RbAp48, is responsible 
for the majority of H3K27me in eukaryotic cells (Cao, Wang et al. 2002) and Ezh2, Suz12, 
and Eed are absolutely essential for H3K27me in vitro (Cao and Zhang 2004).  Furthermore, 
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aberrant HOX gene expression upon loss of Ezh2 function, as well as its fly counterpart E(z), 
is accompanied by loss of H3K27me at these promoters (Cao, Wang et al. 2002). 
The mechanism driving chromatin modifying enzyme targeting represents a major 
question in modern transcription research.  While several of these enzymes harbor domains 
with demonstrated DNA binding potential (Martin and Zhang 2005), primary DNA sequence 
can not be the only deciding factor in their recruitment.  First, the average DNA binding 
domain can recognize motifs which exist tens of thousands of times in higher eukaryotic 
genomes (Hannenhalli 2008).  Furthermore, chromatin modifiers are differentially targeted in 
any number of cellular lineages which contain identical DNA sequence (Ku, Koche et al. 
2008).  The study of Polycomb mediated gene silencing has provided valuable insight into 
the mechanism of complex targeting in Drosophila as directed by defined Polycomb 
Responsive Elements (PREs) (reviewed in (Schwartz and Pirrotta 2008)).  These genomic 
elements can coordinate the binding of the PRC2 through sequence specific interactions with 
DNA binding proteins such as PHO/YY1 (Mohd-Sarip, van der Knaap et al. 2006).  
However, a mechanism for selective PRC2 binding throughout cellular lineages, as well as 
homologous elements in mammalian cells, has yet to be described. 
In addition to extending our knowledge regarding chromatin modification and 
transcriptional competence, studies of PcG mediated silencing have also highlighted the role 
of specific histone modifications in the recruitment of additional factors which contain 
distinct protein domains.  These domains are highly conserved throughout evolution and are 
present in a variety of transcriptional coactivators, corepressors, and chromatin structural 
components (reviewed in (Daniel, Pray-Grant et al. 2005; Zhang 2006)).  Specific binding of 
acetylated lysine residues has been attributed to bromodomains, while lysine binding at 
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various methylation states and residues has been linked to chromo, PHD, WD-40 and Tudor 
domains (Zhang 2006).  In addition to the catalytic core described above, the PRC1 complex 
also contains component Pc which possesses a chromodomain with H3K27me3 binding 
potential.  This association has established a molecular mechanism whereby the direct result 
of PRC2 HMT activity can recruit PRC1dependent ubiquitin ligase activity.  Interestingly, 
this mechanistic insight can explain the genetic interaction of these two distinct protein 
complexes (Cao, Wang et al. 2002; Fischle, Wang et al. 2003). 
While it is impossible to understate the importance of PcG proteins in multicellular 
organism development, both PRC1 and PRC2 have been linked to a variety of biological 
functions that are not limited to HOX gene regulation.  For example, PRC2 mediated gene 
repression is crucial for the establishment and maintenance of XCI (Plath, Fang et al. 2003), 
the maintenance of embryonic stem cell pluripotency (Pasini, Bracken et al. 2007), and the 
silencing of key tumor suppressor genes in mammalian cells (Bracken, Kleine-Kohlbrecher 
et al. 2007; Kotake, Cao et al. 2007).  Additionally, PRC1 has been implicated in XCI 
(Schoeftner, Sengupta et al. 2006) as well as tumor suppressor silencing (Kotake, Cao et al. 
2007).  Knock-out of PRC1 complex components results in the upregulation of p15Ink4a and 
the activation of a pRB mediated cellular senescence program (Kotake, Cao et al. 2007). 
The genomics age 
 Recent technological advances have opened the door to genome wide localization 
studies of chromatin remodeling factors and the covalent modifications they enact (Schones 
and Zhao 2008).  Chromatin immunoprecipitation coupled to genomic microarrays (ChIP-
chip) or high throughput sequencing (ChIP-seq) have led to genome wide identification of 
factor binding sites and histone modifications in numerous cell types that span organism 
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phylogeny.  These powerful techniques have enabled the extrapolation of what may be 
individual target gene regulation events to the definition of general trends in regulatory 
mechanisms and are proving to be instrumental in the mechanistic dissection of complex 
factor targeting in higher eukaryotes (Mendenhall and Bernstein 2008).   
 Over one hundred years of scientific experimentation has fueled the evolution of our 
understanding regarding the importance of chromatin in gene transcription and the regulation 
of virtually all fundamental biological processes.  The identification of modified histones, the 
elucidation of the enzymes which catalyze covalent linkage, and the identification of distinct 
protein domains which possess modification state binding properties has led to formation of 
the histone code hypothesis (Strahl and Allis 2000).  This posits that the combination of 
covalent modifications within a given gene regulatory region can dictate its transcriptional 
competence.  Furthermore, regulation is the result of both intrinsic nucleosome stability, as 
well as additional effector proteins which can recognize and bind to a given cohort of marks.  
Most importantly, the hypothesis suggests that a clear understanding of the interplay between 
all of these factors could allow for transcriptional manipulation of biological systems.  This 
manipulation would have a dramatic impact on our ability to understand and treat a multitude 
of human diseases. 
RESEARCH SUMMARY 
My dissertation highlights the use of four separate analytical methods that are 
commonly employed in chromatin research:  phylogenetic analysis, biochemistry, molecular 
genetics and genome-wide localization.  These technical categories are used to examine three 
chromatin related questions.  First, can the conservation of JmjC domains reveal distinct 
classes of histone demethylases as defined by evolutionary conservation and maintenance of 
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amino acid residues critical for activity?  Second, what is the biochemical activity and 
molecular function of a specific histone demethylase, Jhdm1b, in primary cells?  Third, what 
is the contribution of PRC1 component Bmi1 to uH2A deposition genome-wide? 
At the commencement of my first project, two pieces of critical information were 
known.  First, the biochemical purification of two histone demethylases linked enzymatic 
activity to the JmjC domain (Tsukada, Fang et al. 2006; Yamane, Toumazou et al. 2006).  
Second, the crystal structure of FIH, a JmjC domain-containing protein implicated in the 
hydroxylation of asparagine residues, had been solved in the presence of important co-factors 
which stimulate activity (Lee, Kim et al. 2003).  This information, coupled with extensive 
database curation, was used to reveal the evolutionary conservation of the JmjC domain-
containing proteins and to predict their ability to catalyze the direct removal of methyl groups 
from histone protein substrates. 
At the time of my second project, our lab had characterized the H3K36me substrate 
specificity of Jhdm1a in vitro and in vivo.  In addition, the phylogenetic studies described 
above had demonstrated extensive JmjC domain homology with Jhdm1b, its mammalian 
paralogue.  However, another report had implicated Jhmd1b in directing methyl group 
removal from H3K4 in vivo (Frescas, Guardavaccaro et al. 2007).  In addition, conflicting 
screens had demonstrated both oncogenic and tumor suppressive potential for Jhdm1b 
(Suzuki, Minehata et al. 2006; Pfau, Tzatsos et al. 2008).  We set out to settle both of these 
apparent discrepancies using a combination of biochemistry and molecular biology in 
primary cells. 
At the time my third project began, the power of ChIP-seq technology had been 
described in a series of studies defining the genome-wide chromatin modification patterns in 
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cells.  However, this technique had never been applied to uH2A.  In addition, the functional 
outcome of Bmi1 dependent uH2A deposition at several target genes had implicated the 
mark in transcriptional repression.  I applied genome-wide studies to define the portion of the 
genome associated with Bmi1-dependent uH2A and to investigate whether the results of 
individual gene studies could be extrapolated genome-wide. 
19 
REFERENCES 
Agger, K., P. A. Cloos, et al. (2007). UTX and JMJD3 are histone H3K27 demethylases 
involved in HOX gene regulation and development. Nature 449(7163): 731-4. 
Allfrey, V. G., R. Faulkner, et al. (1964). Acetylation And Methylation Of Histones And 
Their Possible Role In The Regulation Of Rna Synthesis. Proc Natl Acad Sci U S A 51: 786-
94. 
Allfrey, V. G., V. C. Littau, et al. (1963). On the role of of histones in regulation ribonucleic 
acid synthesis in the cell nucleus. Proc Natl Acad Sci U S A 49: 414-21. 
Bannister, A. J., P. Zegerman, et al. (2001). Selective recognition of methylated lysine 9 on 
histone H3 by the HP1 chromo domain. Nature 410(6824): 120-4. 
Barsoum, J. and A. Varshavsky (1985). Preferential localization of variant nucleosomes near 
the 5'-end of the mouse dihydrofolate reductase gene. J Biol Chem 260(12): 7688-97. 
Bell, O., C. Wirbelauer, et al. (2007). Localized H3K36 methylation states define histone 
H4K16 acetylation during transcriptional elongation in Drosophila. Embo J 26(24): 4974-84. 
Benevolenskaya, E. V. (2007). Histone H3K4 demethylases are essential in development and 
differentiation. Biochem Cell Biol 85(4): 435-43. 
Berger, S. L., T. Kouzarides, et al. (2009). An operational definition of epigenetics. Genes 
Dev 23(7): 781-3. 
Bracken, A. P., D. Kleine-Kohlbrecher, et al. (2007). The Polycomb group proteins bind 
throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21(5): 
525-30. 
Brenner, S., F. Jacob, et al. (1961). An unstable intermediate carrying information from 
genes to ribosomes for protein synthesis. Nature 190(4776): 576-581. 
Brownell, J. E. and C. D. Allis (1995). An activity gel assay detects a single, catalytically 
active histone acetyltransferase subunit in Tetrahymena macronuclei. Proc Natl Acad Sci U S 
A 92(14): 6364-8. 
20 
Buchwald, G., P. van der Stoop, et al. (2006). Structure and E3-ligase activity of the Ring-
Ring complex of polycomb proteins Bmi1 and Ring1b. Embo J 25(11): 2465-74. 
Burlingame, R. W., W. E. Love, et al. (1985). Crystallographic structure of the octameric 
histone core of the nucleosome at a resolution of 3.3 A. Science 228(4699): 546-53. 
Cao, R., Y. Tsukada, et al. (2005). Role of Bmi-1 and Ring1A in H2A ubiquitylation and 
Hox gene silencing. Mol Cell 20(6): 845-54. 
Cao, R., L. Wang, et al. (2002). Role of histone H3 lysine 27 methylation in Polycomb-group 
silencing. Science 298(5595): 1039-43. 
Cao, R. and Y. Zhang (2004). The functions of E(Z)/EZH2-mediated methylation of lysine 
27 in histone H3. Curr Opin Genet Dev 14(2): 155-64. 
Cao, R. and Y. Zhang (2004). SUZ12 is required for both the histone methyltransferase 
activity and the silencing function of the EED-EZH2 complex. Mol Cell 15(1): 57-67. 
Ciechanover, A. (1994). The ubiquitin-proteasome proteolytic pathway. Cell 79(1): 13-21. 
Crick, F. (1970). Central dogma of molecular biology. Nature 227(5258): 561-3. 
Culhane, J. C. and P. A. Cole (2007). LSD1 and the chemistry of histone demethylation. 
Curr Opin Chem Biol 11(5): 561-8. 
Daniel, J. A., M. G. Pray-Grant, et al. (2005). Effector proteins for methylated histones: an 
expanding family. Cell Cycle 4(7): 919-26. 
Davie, J. R. and L. C. Murphy (1990). Level of ubiquitinated histone H2B in chromatin is 
coupled to ongoing transcription. Biochemistry 29(20): 4752-7. 
DeLange, R. J., D. M. Fambrough, et al. (1969). Calf and pea histone IV. II. The complete 
amino acid sequence of calf thymus histone IV; presence of epsilon-N-acetyllysine. J Biol 
Chem 244(2): 319-34. 
DeLange, R. J., J. A. Hooper, et al. (1973). Histone 3. 3. Sequence studies on the cyanogen 
bromide peptides; complete amino acid sequence of calf thymus histone 3. J Biol Chem 
248(9): 3261-74. 
21 
Dillon, S. C., X. Zhang, et al. (2005). The SET-domain protein superfamily: protein lysine 
methyltransferases. Genome Biol 6(8): 227. 
Elderkin, S., G. N. Maertens, et al. (2007). A phosphorylated form of Mel-18 targets the 
Ring1B histone H2A ubiquitin ligase to chromatin. Mol Cell 28(1): 107-20. 
Feng, Q., H. Wang, et al. (2002). Methylation of H3-lysine 79 is mediated by a new family of 
HMTases without a SET domain. Curr Biol 12(12): 1052-8. 
Fischle, W., Y. Wang, et al. (2003). Molecular basis for the discrimination of repressive 
methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev 
17(15): 1870-81. 
Forneris, F., C. Binda, et al. (2005). Histone demethylation catalysed by LSD1 is a flavin-
dependent oxidative process. FEBS Lett 579(10): 2203-7. 
Frescas, D., D. Guardavaccaro, et al. (2007). JHDM1B/FBXL10 is a nucleolar protein that 
represses transcription of ribosomal RNA genes. Nature 450(7167): 309-13. 
Goldknopf, I. L. and H. Busch (1977). Isopeptide linkage between nonhistone and histone 2A 
polypeptides of chromosomal conjugate-protein A24. Proc Natl Acad Sci U S A 74(3): 864-8. 
Goldstein, G., M. Scheid, et al. (1975). Isolation of a polypeptide that has lymphocyte-
differentiating properties and is probably represented universally in living cells. Proc Natl 
Acad Sci U S A 72(1): 11-5. 
Hannenhalli, S. (2008). Eukaryotic transcription factor binding sites--modeling and 
integrative search methods. Bioinformatics 24(11): 1325-31. 
Hicke, L. (2001). Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2(3): 195-201. 
Honda, B. M., G. H. Dixon, et al. (1975). Sites of in vivo histone methylation in developing 
trout testis. J Biol Chem 250(22): 8681-5. 
Huang, R. C. and J. Bonner (1962). Histone, a suppressor of chromosomal RNA synthesis. 
Proc Natl Acad Sci U S A 48: 1216-22. 
Hurwitz, J. (2005). The discovery of RNA polymerase. J Biol Chem 280(52): 42477-85. 
22 
Iwase, S., F. Lan, et al. (2007). The X-linked mental retardation gene SMCX/JARID1C 
defines a family of histone H3 lysine 4 demethylases. Cell 128(6): 1077-88. 
Klose, R. J., E. M. Kallin, et al. (2006). JmjC-domain-containing proteins and histone 
demethylation. Nat Rev Genet 7(9): 715-27. 
Klose, R. J., K. Yamane, et al. (2006). The transcriptional repressor JHDM3A demethylates 
trimethyl histone H3 lysine 9 and lysine 36. Nature 442(7100): 312-6. 
Klose, R. J., Q. Yan, et al. (2007). The retinoblastoma binding protein RBP2 is an H3K4 
demethylase. Cell 128(5): 889-900. 
Kornberg, R. D. (1974). Chromatin structure: a repeating unit of histones and DNA. Science 
184(139): 868-71. 
Kornberg, R. D. and Y. Lorch (1999). Twenty-five years of the nucleosome, fundamental 
particle of the eukaryote chromosome. Cell 98(3): 285-94. 
Kornberg, R. D. and J. O. Thomas (1974). Chromatin structure; oligomers of the histones. 
Science 184(139): 865-8. 
Kotake, Y., R. Cao, et al. (2007). pRB family proteins are required for H3K27 trimethylation 
and Polycomb repression complexes binding to and silencing p16INK4alpha tumor 
suppressor gene. Genes Dev 21(1): 49-54. 
Ku, M., R. P. Koche, et al. (2008). Genomewide analysis of PRC1 and PRC2 occupancy 
identifies two classes of bivalent domains. PLoS Genet 4(10): e1000242. 
Lee, C., S. J. Kim, et al. (2003). Structure of human FIH-1 reveals a unique active site pocket 
and interaction sites for HIF-1 and von Hippel-Lindau. J Biol Chem 278(9): 7558-63. 
Lee, J. S., A. Shukla, et al. (2007). Histone crosstalk between H2B monoubiquitination and 
H3 methylation mediated by COMPASS. Cell 131(6): 1084-96. 
Levy-Wilson, B. (1983). Glycosylation, ADP-ribosylation, and methylation of Tetrahymena 
histones. Biochemistry 22(2): 484-9. 
23 
Li, B., M. Gogol, et al. (2007). Infrequently transcribed long genes depend on the 
Set2/Rpd3S pathway for accurate transcription. Genes Dev 21(11): 1422-30. 
Li, B., J. Jackson, et al. (2009). Histone H3 Lysine 36 Dimethylation (H3K36me2) Is 
Sufficient to Recruit the Rpd3s Histone Deacetylase Complex and to Repress Spurious 
Transcription. J Biol Chem 284(12): 7970-6. 
Luger, K., A. W. Mader, et al. (1997). Crystal structure of the nucleosome core particle at 2.8 
A resolution. Nature 389(6648): 251-60. 
Martin, C. and Y. Zhang (2005). The diverse functions of histone lysine methylation. Nat 
Rev Mol Cell Biol 6(11): 838-49. 
McGinty, R. K., J. Kim, et al. (2008). Chemically ubiquitylated histone H2B stimulates 
hDot1L-mediated intranucleosomal methylation. Nature 453(7196): 812-6. 
Mendenhall, E. M. and B. E. Bernstein (2008). Chromatin state maps: new technologies, new 
insights. Curr Opin Genet Dev 18(2): 109-15. 
Metzger, E., M. Wissmann, et al. (2005). LSD1 demethylates repressive histone marks to 
promote androgen-receptor-dependent transcription. Nature 437(7057): 436-9. 
Mikkelsen, T. S., M. Ku, et al. (2007). Genome-wide maps of chromatin state in pluripotent 
and lineage-committed cells. Nature 448(7153): 553-60. 
Mohd-Sarip, A., J. A. van der Knaap, et al. (2006). Architecture of a polycomb nucleoprotein 
complex. Mol Cell 24(1): 91-100. 
Moore, S., D. H. Spackman, et al. (1958). Automatic recording apparatus for use in the 
chromatography of amino acids. Fed Proc 17(4): 1107-15. 
Morris, S. A., Y. Shibata, et al. (2005). Histone H3 K36 methylation is associated with 
transcription elongation in Schizosaccharomyces pombe. Eukaryot Cell 4(8): 1446-54. 
Murray, K. (1964). The Occurrence Of Epsilon-N-Methyl Lysine In Histones. Biochemistry 
3: 10-5. 
24 
Oki, M., H. Aihara, et al. (2007). Role of histone phosphorylation in chromatin dynamics and 
its implications in diseases. Subcell Biochem 41: 319-36. 
Olins, A. L. and D. E. Olins (1974). Spheroid chromatin units (v bodies). Science 183(4122): 
330-2. 
Ord, M. G. and L. A. Stocken (1966). Metabolic properties of histones from rat liver and 
thymus gland. Biochem J 98(3): 888-97. 
Paik, W. K. and S. Kim (1970). Omega-N-methylarginine in histones. Biochem Biophys Res 
Commun 40(1): 224-9. 
Pasini, D., A. P. Bracken, et al. (2007). The polycomb group protein Suz12 is required for 
embryonic stem cell differentiation. Mol Cell Biol 27(10): 3769-79. 
Pfau, R., A. Tzatsos, et al. (2008). Members of a family of JmjC domain-containing 
oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc 
Natl Acad Sci U S A 105(6): 1907-12. 
Phillips, D. M. (1963). The presence of acetyl groups of histones. Biochem J 87: 258-63. 
Plath, K., J. Fang, et al. (2003). Role of histone H3 lysine 27 methylation in X inactivation. 
Science 300(5616): 131-5. 
Rao, B., Y. Shibata, et al. (2005). Dimethylation of histone H3 at lysine 36 demarcates 
regulatory and nonregulatory chromatin genome-wide. Mol Cell Biol 25(21): 9447-59. 
Rasmussen, P. S., K. Murray, et al. (1962). On the complexity of calf thymus histone. 
Biochemistry 1: 79-89. 
Rea, S., F. Eisenhaber, et al. (2000). Regulation of chromatin structure by site-specific 
histone H3 methyltransferases. Nature 406(6796): 593-9. 
Ringrose, L. and R. Paro (2004). Epigenetic regulation of cellular memory by the Polycomb 
and Trithorax group proteins. Annu Rev Genet 38: 413-43. 
Robzyk, K., J. Recht, et al. (2000). Rad6-dependent ubiquitination of histone H2B in yeast. 
Science 287(5452): 501-4. 
25 
Schoeftner, S., A. K. Sengupta, et al. (2006). Recruitment of PRC1 function at the initiation 
of X inactivation independent of PRC2 and silencing. Embo J 25(13): 3110-22. 
Schones, D. E. and K. Zhao (2008). Genome-wide approaches to studying chromatin 
modifications. Nat Rev Genet 9(3): 179-91. 
Schwartz, Y. B. and V. Pirrotta (2008). Polycomb complexes and epigenetic states. Curr 
Opin Cell Biol 20(3): 266-73. 
Shi, Y., F. Lan, et al. (2004). Histone demethylation mediated by the nuclear amine oxidase 
homolog LSD1. Cell 119(7): 941-53. 
Shiio, Y. and R. N. Eisenman (2003). Histone sumoylation is associated with transcriptional 
repression. Proc Natl Acad Sci U S A 100(23): 13225-30. 
Stedman, E. (1950). Cell specificity of histones. Nature 166(4227): 780-1. 
Strahl, B. D. and C. D. Allis (2000). The language of covalent histone modifications. Nature 
403(6765): 41-5. 
Strahl, B. D., P. A. Grant, et al. (2002). Set2 is a nucleosomal histone H3-selective 
methyltransferase that mediates transcriptional repression. Mol Cell Biol 22(5): 1298-306. 
Strahl, B. D., R. Ohba, et al. (1999). Methylation of histone H3 at lysine 4 is highly 
conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad 
Sci U S A 96(26): 14967-72. 
Sun, X. J., J. Wei, et al. (2005). Identification and characterization of a novel human histone 
H3 lysine 36-specific methyltransferase. J Biol Chem 280(42): 35261-71. 
Suzuki, T., K. Minehata, et al. (2006). Tumor suppressor gene identification using retroviral 
insertional mutagenesis in Blm-deficient mice. Embo J 25(14): 3422-31. 
Swigut, T. and J. Wysocka (2007). H3K27 demethylases, at long last. Cell 131(1): 29-32. 
Takeuchi, T., Y. Watanabe, et al. (2006). Roles of jumonji and jumonji family genes in 
chromatin regulation and development. Dev Dyn 235(9): 2449-59. 
26 
Taunton, J., C. A. Hassig, et al. (1996). A mammalian histone deacetylase related to the yeast 
transcriptional regulator Rpd3p. Science 272(5260): 408-11. 
Thoma, F. and T. Koller (1977). Influence of histone H1 on chromatin structure. Cell 12(1): 
101-7. 
Thorne, A. W., P. Sautiere, et al. (1987). The structure of ubiquitinated histone H2B. Embo J 
6(4): 1005-10. 
Tsukada, Y., J. Fang, et al. (2006). Histone demethylation by a family of JmjC domain-
containing proteins. Nature 439(7078): 811-6. 
Various (1971). Histones and Nucleohistones. New York, Plenum Publishing Company Ltd. 
Various (1988). Ubiquitin. New York, Plenum Press. 
Wang, H., L. Wang, et al. (2004). Role of histone H2A ubiquitination in Polycomb silencing. 
Nature 431(7010): 873-8. 
Weintraub, H. and F. Van Lente (1974). Dissection of chromosome structure with trypsin 
and nucleases. Proc Natl Acad Sci U S A 71(10): 4249-53. 
West, M. H. and W. M. Bonner (1980). Histone 2B can be modified by the attachment of 
ubiquitin. Nucleic Acids Res 8(20): 4671-80. 
Wu, X., Y. Gong, et al. (2008). Cooperation between EZH2, NSPc1-mediated histone H2A 
ubiquitination and Dnmt1 in HOX gene silencing. Nucleic Acids Res 36(11): 3590-9. 
Wysocka, J., C. D. Allis, et al. (2006). Histone arginine methylation and its dynamic 
regulation. Front Biosci 11: 344-55. 
Yamane, K., K. Tateishi, et al. (2007). PLU-1 is an H3K4 demethylase involved in 
transcriptional repression and breast cancer cell proliferation. Mol Cell 25(6): 801-12. 
Yamane, K., C. Toumazou, et al. (2006). JHDM2A, a JmjC-containing H3K9 demethylase, 
facilitates transcription activation by androgen receptor. Cell 125(3): 483-95. 
27 
28 
Zhang, Y. (2006). It takes a PHD to interpret histone methylation. Nat Struct Mol Biol 13(7): 
572-4. 
Zhou, W., X. Wang, et al. (2009). Histone H2A ubiquitination in transcriptional regulation 
and DNA damage repair. Int J Biochem Cell Biol 41(1): 12-5. 
 
 
  
Chapter 2 
The evolutionarily conserved Jumonji C domain-containing proteins can 
be separated into seven groups based on domain architecture and 
phylogenetic relationship 
 
 
This chapter is the result of collaboration with Dr. Robert J. Klose and portions of this text 
are taken from a co-authored review published on the topic (Klose, R.J., Kallin E.M., and 
Zhang, Y. Nat. Rev. Genetics. 2006).  I carried out all of the described bioinformatic analysis. 
 
ABSTRACT 
Histone methylation plays important roles in regulating gene expression and forms 
part of the epigenetic memory system that regulates cell fate and identity.  Recently, enzymes 
capable of directly removing methyl marks from histones have been identified, revealing a 
new level of plasticity within this epigenetic modification system.  Here we analyze the 
evolutionary relationship between JmjC domain containing proteins with the goal of 
predicting additional active demethylases. 
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INTRODUCTION 
The basic unit of chromatin consists of 146 bp of DNA wrapped around a histone 
octamer which is composed of two copies of each of the four core histones H2A, H2B, H3, 
and H4.  Covalent modification of core histones modulates genome function by contributing 
additional epigenetic information.  One such modification is methylation, which occurs on 
arginine and lysine residues and is involved in regulating a wide range of chromatin based 
processes (reviewed in (Martin and Zhang 2005)).  While arginine residues can be 
methylated to mono- and di- states, lysine residues can house one to three (mono, di, tri) 
methyl groups.  The histone modification state of a given residue can have profound affects 
on the function of chromatin.  
The identification and characterization of histone methyltransferase enzymes has 
provided a wealth of knowledge regarding the effects of distinct histone methylation marks 
on chromatin function.  Until recently, it was not known whether enzymes capable of 
antagonizing histone methylation existed.  However, during the past two years, three distinct 
classes of enzyme capable of antagonizing histone methylation have been characterized. 
PADI4 was the first of these enzymes identified and it functions as a histone deiminase that 
converts methyl-arginine to citrulline as opposed to directly reversing arginine methylation 
(Cuthbert, Daujat et al. 2004; Wang, Wysocka et al. 2004).  Lysine Specific Demethylase 1 
(LSD1) was the founding member of the second class of enzymes which directly reverses 
histone H3K4/K9 lysine modifications by an oxidative demethylation reaction requiring 
flavin as a co-factor (Shi, Lan et al. 2004; Metzger, Wissmann et al. 2005).  The third, and 
largest class of demethylase enzymes, contain a JmjC domain and catalyze histone lysine 
demethylation via an oxidative reaction that requires iron Fe(II) and alpha-ketoglutarate 
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(αKG) as co-factors (Tsukada, Fang et al. 2006).  Unlike LSD1, which can only remove 
mono and di-methyl lysine modifications, the JmjC domain containing histone demethylases 
are capable of removing all three histone lysine methylation states.  Thus far, JmjC domain 
containing histone demethylases (JHDMs) have been shown to reverse H3K36 (JHMD1) 
(Tsukada, Fang et al. 2006), H3K9 (JHDM2A, JHDM3B/D) (Yamane, Toumazou et al. 
2006) and both H3K9/36 (JHDM3A/C) methylation (Klose, Yamane et al. 2006; Whetstine, 
Nottke et al. 2006).  
The JmjC domain was first defined based on amino acid similarities in the Jarid2 
(Jumonji), Jarid1C (Smcx), and Jarid1A (RBP2) proteins (Takeuchi, Yamazaki et al. 1995; 
Balciunas and Ronne 2000; Clissold and Ponting 2001).  Homology between the JmjC and 
cupin metalloenzyme domains (Dunwell and Gane 1998; Clissold and Ponting 2001) led to 
the identification of the JmjC domain containing factor inhibiting hypoxia (FIH) as an active 
protein hydroxylase (Lando, Peet et al. 2002).  Given that several JmjC domain-containing 
proteins are known to associate with chromatin, it was proposed that some members of this 
protein family may carry out histone demethylation reactions using a mechanism analogous 
to the AlkB family of DNA demethylases (Trewick, McLaughlin et al. 2005; Tsukada, Fang 
et al. 2006).  This prediction was confirmed through an unbiased activity-based biochemical 
purification which identified a JmjC domain-containing protein, JHDM1, as a H3K36-
specific demethylase (Tsukada, Fang et al. 2006).  Based on the crystal structure of FIH, the 
JmjC domain folds into eight beta sheets forming an enzymatically active pocket which 
coordinates Fe(II) and αKG (Dann, Bruick et al. 2002; Elkins, Hewitson et al. 2003; Lee, 
Kim et al. 2003).  Within the JmjC domain, three amino acid residues are involved in binding 
to the cofactor Fe(II), and two additional residues contact with αKG.  Many JmjC domain-
32 
containing proteins have conserved residues within the predicted co-factor binding sites 
indicating that these proteins may be active enzymes, while other members have amino acids 
variations which are likely to abrogate enzymatic activity.  Substrate specificity for JmjC 
domain containing histone demethylases appears to rely on both the JmjC domain and 
additional domains found within each enzyme. 
Here we have analyzed JmjC domain-containing proteins from yeast, worm, fly, 
mouse, and human.  By utilizing bioinformatic analysis we provide new insight into JmjC 
domain homology, protein domain architecture, and enzymatic activity.  Based on our 
analysis, we predict that many more JmjC domain-containing proteins are likely to function 
as protein hydroxylases or histone demethylases. 
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RESULTS 
Through analysis of public protein domain databases including PFAM and SMART, 
we have extracted a non-redundant set of 98 JmjC domain-containing proteins from various 
organisms including: human (30), mouse (30), D. melanogaster (13), C.elegans (13), 
S.pombe (7), and S.cerevisiae (5) (Table 2-1).  A combination of multiple sequence 
alignment (Chenna, Sugawara et al. 2003) and bayesian inference phylogeny (Huelsenbeck 
and Ronquist 2001; Ronquist and Huelsenbeck 2003) was used to visualize the evolutionary 
relationship between the JmjC domains of the proteins within our database (Fig. 2-1).  We 
then divided the JmjC domain-containing proteins into seven groups by merging information 
regarding the domain architecture of the full length protein with JmjC domain based 
phylogeny (Fig. 2-1).  Using this classification scheme, we have defined seven groups of 
evolutionarily conserved proteins, six of which have at least one additional protein domain 
beside the JmjC domain, and a seventh group that contains only a JmjC domain (Fig. 2-1).  
To further analyze the JmjC domain within individual groups, we focused on amino acid 
conservation within predicted Fe(II) and αKG binding sites to provide additional insight into 
potential enzymatic activity.  To this end, all proteins that contain a JmjC domain that 
demonstrate conserved cofactor binding amino acids were identified (Fig. 2-1, solid 
triangles). 
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DISCUSSION 
In 2000, the SET domain was identified as the enzymatic motif shared amongst a 
broad class of histone methyltransferase enzymes (Rea, Eisenhaber et al. 2000).  Since then 
there has been an exponential growth in our understanding of how histone methylation 
contributes to chromatin function (Martin and Zhang 2005).  With the identification of 
enzymes that antagonize histone methylation (Cuthbert, Daujat et al. 2004; Shi, Lan et al. 
2004; Wang, Wysocka et al. 2004; Tsukada, Fang et al. 2006), we appear to be on the cusp of 
another rapid advancement in our understanding of histone methylation.   
Although it is clear that not all JmjC domain-containing proteins will be functional 
enzymes, our analysis suggests that many of these proteins satisfy the co-factor binding 
requirements and appear to be excellent candidates for histone or non-histone protein 
demethylases.  The specific roles that individual histone or non-histone protein demethylases 
will play in normal cellular function remains to be revealed, but it is clear that histone 
methylation can be dynamically regulated in a manner analogous to acetylation or 
phosphorylation.  The histone demethylases identified thus far have roles in counteracting 
histone modifications that oppose the transcription state of a given gene and in removing 
histone modifications during the transition from one transcriptional state to another.  With the 
constantly expanding repertoire of site-specific histone demethylases, we look forward to 
determining how these unique enzymes will function in regulating transcription, epigenetic 
inheritance, and in controlling cell fate.   
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EXPERIMENTAL PROCEDURES 
Database curation and phylogenetic tree generation:  The SMART (Schultz, Milpetz et al. 
1998; Letunic, Copley et al. 2006) and the PFAM domain databases (Bateman, Coin et al. 
2004) were used to obtain a list of all JmjC domain containing proteins from: human, mouse, 
D. melanogaster, C. elegans, fission yeast, and budding yeast.  This list was then curated by 
extracting the chromosome location of all entries.  Any JmjC domain containing proteins that 
were linked to the same physical chromosome location were aligned using Multalin (Corpet 
1988) to eliminate any redundancy in our curated JmjC domain containing data set.  Within 
our curated JmjC domain-containing protein database we have included: 30 human proteins, 
30 mouse proteins, 13 D. melanogastar proteins, 13 C. elegans proteins, 7 fission yeast 
proteins and 5 budding yeast proteins.  A multiple sequence alignment of the JmjC domain 
was performed using ClustalW (Corpet 1988; Chenna, Sugawara et al. 2003) followed by 
phylogenetic tree generation using a mixed amino acid model and 2.2 million generations 
with sampling every 1000th generation using Mr. Bayes (Huelsenbeck and Ronquist 2001; 
Ronquist and Huelsenbeck 2003).  The resulting tree was imported into Mega 3.1 (Kumar, 
Tamura et al. 2004) for visualization and analysis.  Based on the phylogenetic tree and the 
domain architecture of the full length proteins we have classified the JmjC domain 
containing proteins into seven groups. 
 
  
 
Figure 2-1.  The phylogenetic relationship between the JmjC (Jumonji C)-domain-containing 
proteins from model organisms.  Multiple sequence alignment followed by Bayesian 
inference analysis was used to compute JmjC domain phylogenetic relationships in several 
model organisms.  All posterior probabilities of clade partitions that were <100% are shown 
and are defined as the percentage of sampled trees used in the analysis that contained the 
consensus partition. Seven evolutionarily conserved groups of JmjC-domain-containing 
proteins were defined by combining information from the phylogenetic analysis (left) and the 
domain architecture of the full-length protein (right). The asterisk indicates proteins that were 
placed in a given group based on homology within the JmjC domain, but that lack some 
aspects of the domain architecture found in their related orthologues. The JmjC-domain-only 
group has been divided into eight subgroups based on similarity within the JmjC domain, as 
determined by phylogenetic analysis alone. Schizosaccharomyces pombe (sp); 
Caenorhabditis elegans (ce); Saccharomyces cerevisiae (sc); Drosophila melanogaster (dm); 
Homo sapiens (hs); Mus musculus (mm).  Conserved residue analysis was used to make 
predictions regarding enzyme activity (◄).   
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Table 2-1.  Annotation of JmjC-domain-containing proteins. 
Organism Name Alternate Names 
Pombe Spac25h1 Spac25h1.02, Jmj1 
Pombe Epe1 SPCC622.16c 
Pombe Spcc622 Jmj4 
Pombe Ecm5 SPBC83.07, Lid2, jmj3 
Pombe Spbp4h10.01 SPBP19A11.06, lid2 
Pombe SPAC1002 Jmj2 
Pombe Q9UT79 SPAC343.11c, msc1 
Human NO66 C14orf169, FLJ21802 
Human JHDM1B FBXL10, CXXC2, Fbl10, PCCX2, JEMMA 
Human JHDM1A 
FBXL11, CXXC8, DKFZP434M1735, FBL11, FBL7, 
FLJ00115, KIAA1004, LILIN 
Human JMJD5 FLJ13798, LOC79831 
Human FIH HIF1AN, DKFZp762F1811, FIH1, FLJ20615, FLJ22027 
Human HR ALUNC, AU, HSA277165 
Human HSPBAP1 FLJ22623, FLJ39386, PASS1 
Human JARID1A RBBP2, RBP2 
Human JARID1B 
2010009J12Rik, 2210016I17Rik, AW556288, D1Ertd202e, 
KIAA4034, PLU-1, PU 
Human JARID1C Smcx, KIAA0234 
Human JARID1D Smcy 
Human JARID2 Jumonji, AI317256, AU045941, C79929, C79931, Jmj 
Human JHDM2A 
JMJD1A, DKFZp686A24246, DKFZp686P07111, JMJD1, 
KIAA0742, TSGA 
Human JHDM2B JMJD1B, 5qNCA, C5orf7, KIAA1082 
Human JHDM2C 
JMJD1C, DKFZp761F0118, FLJ14374, KIAA1380, RP11-
10C13.2, TRIP8 
Human JHDM3A JMJD2A, JMJD2, KIAA0677 
Human JHDM3B JMJD2B, KIAA0876 
Human JHDM3C JMJD2C, GASC1, KIAA0780, bA146B14.1 
Human JHDM3D JMJD2D, FLJ10251 
Human JMJD3 
RP23-5O23.5, 1700064E03Rik, BC038313, KIAA0346, 
mKIAA0346 
Human JMJD4 RP23-210M6.10, 6430559I23, AU020939 
Human KIAA1718 
Human LOC339123 PP14397 
Human MINA53 DKFZp762O1912, FLJ14393, MDIG, MINA, NO52 
Human PHF2 GRC5, KIAA0662 
Human PHF8 RP13-444K19.2, DKFZp686E0868, KIAA1111, ZNF422 
Human PLA2G4B HsT16992, cPLA2-beta 
Human PTDSR PSR, KIAA0585, PTDSR1 
Human UTX RP13-886N14.3, DKFZp686A03225, bA386N14.2 
  39 
Human UTY UTY1 
Worm rbr-2 ZK593.4 
Worm XJ181 D2021.1 
Worm 5L609 C06H2.3 
Worm 4F419 psr-1, F29B9.4, tag-159 
Worm 2O526 Y48B6A.11 
Worm XO59 C29F7.6 
Worm XP71 F23D12.5 
Worm CE20788 F43G6.6, 2M97, spt-3 
Worm 3H549 T26A5.5 
Worm XJ193 tag-279, F18E9.5 
Worm 4F429 F29B9.2 
Worm 1E200 T28F2.4 
Worm 3g50 C27F2.5 
Fly CG13902 
Fly CG15835 
Fly CG33182 CG4037 
Fly CG5383 L0022859, PS, dPSR, PSR 
Fly CG8165 CG31123 
Fly CG5640 
Fly Lid CG9088, lid, l(2)10424 
Fly CG2982 
Fly CG12879 
Fly CG11033 
Fly CG7200 
Fly CG3654 
Fly CG10133 
Cerevisiae Jhd1 YER051W 
Cerevisiae Rph1 YER169W 
Cerevisiae Yjr119c 
Cerevisiae Ecm5 YMR176W 
Cerevisiae Gis1 YDR096W 
Mouse No66 2410016O06Rik 
Mouse 2610003J06Rik 
Mouse Jmjd5 LOC77035, 3110005O21Rik 
Mouse Jmjd2d Jmjd2d, 4932416A15 
Mouse Kiaa1718 BB041802, A630082K20Rik 
Mouse Jhdm1b 
Fbxl10, Cxxc2, E430001G17, Fbl10, KIAA3014, PCCX2, 
mKIAA3014 
Mouse Jhdm1a Fbxl11, Cxxc8, Fbl11, Fbl7, lalina 
Mouse Fih Hif1an, 2310046M24Rik, A830014H24Rik, FIH1 
Mouse Hr ALUNC, AU,N, ba,rh, rh-bmh, rhino 
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 Mouse Hspbap1 3830421G21Rik 
Mouse Jarid1a RBBP2, RBP2 
Mouse Jarid1b 
2010009J12Rik, 2210016I17Rik, AW556288, D1Ertd202e, 
KIAA4034, PLU-1, PU 
Mouse Jarid1c Smcx, mKIAA0234 
Mouse Jarid1d Smcy 
Mouse Jarid2 AI317256, AU045941, C79929, C79931, Jmj 
Mouse Jhdm2a 
Jmjd1a, 1700105C21Rik, C230043E16Rik, Jmjd1, TGSA, 
Tsga, mKIAA0742 
Mouse Jhdm2b Jmjd1b, 5830462I21Rik, mKIAA1082 
Mouse Jhdm2c Jmjd1c, 5430433L24Rik, D630035I23Rik, Jmjdic, TRIP8 
Mouse Jhdm3a Jmjd2a, JMJD2, KIAA0677 
Mouse Jhdm3b Jmjd2b, KIAA0876 
Mouse Jhdm3c Jmjd2c, GASC1, KIAA0780, bA146B14.1 
Mouse Jhdm3d 
Jmjd3, RP23-5O23.5, 1700064E03Rik, BC038313, KIAA0346, 
mKIAA0346 
Mouse Jmjd4 RP23-210M6.10, 6430559I23, AU020939 
Mouse Mina53 
Mina, 1810047J07Rik, 2410057H13Rik, 3830408E23Rik, 
AI449204 
Mouse Phf2 
Mouse Phf8 9830141C09Rik, mKIAA1111 
Mouse Pla2g4b HsT16992, cPLA2-beta 
Mouse Ptdsr 5730436I23Rik, D11Ertd195e, PSR, PtdSerR, mKIAA0585 
Mouse Utx RP13-886N14.3, DKFZp686A03225, bA386N14.2 
Mouse Uty UTY1 
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Chapter 3 
The H3K36 demethylase Jhdm1b/Kdm2b regulates 
cell proliferation and senescence through p15Ink4b 
 
 
This chapter is the result of collaboration with Dr. Jin He.  I directly contributed on  
Figure 3-1, 3-4C, 3-4D, 3-4E, S3-1, S3-2 and S3-3A.  In addition I provided reagents used to 
generate Figures 3-4A and 3-4B. 
 
ABSTRACT 
The Ink4a/Arf/Ink4b locus plays a critical role in both cellular senescence and 
tumorigenesis. Jhdm1b/Kdm2b/Fbxl10, the mammalian paralogue of the histone demethylase 
Jhdm1a/Kdm2a/Fbxl11, has been implicated in cell cycle regulation and tumorigenesis. In 
this report, we demonstrate that Jhdm1b is an H3K36 demethylase. Knockdown of Jhdm1b 
in primary MEFs inhibits cell proliferation and induces cellular senescence in a pRb and p53 
pathway-dependent manner. Importantly, the effect of Jhdm1b on cell proliferation and 
cellular senescence is mediated through de-repression of p15Ink4b as loss of p15Ink4b function 
rescues cell proliferation defects in Jhdm1b knockdown cells. Chromatin 
immunoprecipitation on ectopically expressed Jhdm1b demonstrates that Jhdm1b targets the 
p15Ink4b locus and regulates its expression in an enzymatic activity-dependent manner. 
Alteration of Jhdm1b level affects Ras-induced neoplastic transformation. Collectively, our 
results indicate that Jhdm1b is an H3K36 demethylase that regulates cell proliferation and 
senescence through p15Ink4b.  
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INTRODUCTION 
The Ink4a/Arf/Ink4b locus encodes three critical cell cycle inhibitors including 
p16Ink4a, p15Ink4b and Arf (p14 in human and p19 in mouse). The two members of the Ink4 
protein family inhibit the binding of D-type cyclins to cyclin dependent kinase 4 and 6 
(Cdk4/6), inhibiting the phosphorylation of retinoblastoma (Rb) family proteins and 
preventing G1/S phase transition in cells. The Arf protein, which shares two common p16Ink4a 
exons but contains a distinct open reading frame, is able to activate the p53 pathway through 
sequestration of the p53 negative regulator Mdm2 (reviewed in (Ortega, Prieto et al. 2003; 
Gil and Peters 2006)). 
The Ink4a/Arf/Ink4b locus plays a critical role in determining cellular response to 
oncogenic signals. In normal cells, inappropriate oncogenic stimulation activates this locus 
and leads to cellular senescence. However, dysregulation of this locus can facilitate 
tumorigenesis through multiple oncogenic signaling pathways. The importance of this locus 
in cellular defense against tumorigenesis is further supported by evidence that 
Ink4a/Arf/Ink4b is frequently deleted or mutated in a variety of human primary tumors 
(Kamb, Gruis et al. 1994; Ogawa, Hirano et al. 1994; Okuda, Shurtleff et al. 1995; 
Kannengiesser, Dalle et al. 2007). In addition, combined deletion of Ink4a/Arf with Ink4b in 
mice results in a broader spectrum of tumors compared to mice with individual genetic 
deletions indicating that genes in this locus work synergistically to prevent tumor 
development and that p15Ink4b is a critical tumor suppressor in the absence of p16Ink4a 
(Krimpenfort, Ijpenberg et al. 2007). Since this locus controls both cellular senescence and 
tumorigenesis, tight regulation is crucial under physiological conditions. Although many 
oncoproteins and Polycomb group proteins have been shown to regulate Ink4a/Arf expression 
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(Bracken, Kleine-Kohlbrecher et al. 2007; Kotake, Cao et al. 2007), the mechanism that 
controls p15Ink4b expression remains unclear. 
The JmjC-domain containing histone demethylase 1b (Jhdm1b) is a paralogue of the 
first identified histone lysine demethylase, Jhdm1a, which targets H3K36 for demethylation 
(Tsukada, Fang et al. 2006). This fact, as well as their high homology within the catalytic 
JmjC domain (79%), led us to predict that the demethylase activity against the H3K36 
methyl group is conserved between both paralogues (Fig. S3-1). However, in a recent report 
Jhdm1b was implicated in the demethylation of H3K4me3 in vivo (Frescas, Guardavaccaro et 
al. 2007). In addition, the reported biological functions of this protein are also controversial. 
Although two groups have identified Jhdm1b as a hotspot for proviral insertion in murine 
tumors generated by random MMLV mutagenesis, the locus has paradoxically been 
identified as an oncogene and a tumor suppressor depending on the screen and functional 
studies used(Suzuki, Minehata et al. 2006; Pfau, Tzatsos et al. 2008). In addition, subsequent 
studies have reported that Jhdm1b was a negative regulator of c-Jun (Koyama-Nasu, David et 
al. 2007) or rRNA genes (Frescas, Guardavaccaro et al. 2007), further implicating Jhdm1b in 
tumor suppression.  
In an effort to resolve these apparent discrepancies, we set out to use methods well 
established in our previous studies to characterize the biochemical properties as well as 
biological function of Jhdm1b using primary MEF cells, which maintain normal cell cycle 
regulatory pathways, to study protein function. We report here that Jhdm1b is an H3K36-
specific histone demethylase that functions to promote cellular proliferation and inhibit 
cellular senescence through the silencing of the p15Ink4b tumor suppressor gene. 
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RESULTS 
Jhdm1b is an H3K36me2-specific demethylase 
In an effort to explain the difference between activity prediction based on domain 
homology and reported in vivo substrate specificity (Frescas, Guardavaccaro et al. 2007), we 
first investigated the in vitro and in vivo catalytic activity of Jhdm1b. To this end, 
recombinant protein was flag-affinity purified from baculovirus-infected Sf9 cells (Fig. S3-
2A), and subjected to an histone demethylase assay by measuring radioactive formaldehyde 
release (Tsukada, Fang et al. 2006). Of all the substrates tested, only the H3K36-specific 
SET2-labeled histone substrate could be demethylated by Jhdm1b, indicating that, as 
predicted, Jhdm1b has a similar substrate specificity to Jhdm1a (Tsukada, Fang et al. 2006) 
(Fig. 3-1A).  
Because Jhdm1b was implicated in the demethylation of H3K4me3 in vivo (Frescas, 
Guardavaccaro et al. 2007), we tested the capacity of Jhdm1b to demethylate H3K4me3 in 
vitro. To this end, we purified a new batch of wild-type Jhdm1b along with a mutant Jhdm1b 
(H211A) predicted to kill the enzymatic activity (Fig. S3-2B). As controls, we also purified 
the H3K36me2-specific demethylase, Jhdm1a (Tsukada, Fang et al. 2006), and the 
H3K4me3-specific demethylase, Rbp2 (Klose, Yan et al. 2007). Incubation of these proteins 
with SET2-labeled histone substrate confirmed efficient formaldehyde release for Jhdm1a 
and Jhdm1b, but not Jhdm1b (H211A) (Fig. 3-1B). In addition, Jhdm1b exhibited about one 
third the activity of JHDM1A when equivalent amount of proteins were assayed. 
Furthermore, incubation of these proteins with substrate labeled by a mutated form of the 
SET7, SET7 (Y245A), which generates K4me2 and K4me3 (Xiao, Jing et al. 2003), did not 
show efficient release of formaldehyde above background. However, incubation of RBP2 
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with the same substrate resulted in formaldehyde release (Fig. 3-1B), demonstrating that 
Jhdm1b has no H3K4me3 demethylase activity under the assay conditions.  
To further define the substrate specificity of Jhdm1b, we incubated the protein with 
core histones purified from HeLa cells and analyzed the product by Western blot using 
methylation state-specific antibodies. These experiments demonstrate that Jhdm1b, like its 
paralogue, JHDM1A, can specifically demethylate H3K36me2 and H3K36me1 histone 
substrates (Fig. 3-1C). However, it does not alter H3K4 methylation levels (Fig. 3-1C). 
To characterize the substrate specificity of Jhdm1b in vivo, we utilized HEK293 cells 
selected for adherence (AD293) and overexpressed Jhdm1b and Jhdm1b (H211A) via 
retroviral infection. Quantitative reverse transcriptase PCR (qRT-PCR) verified similar levels 
of stable expression of wild-type and the mutant Jhdm1b (Fig. 3-1D). Western blot analysis 
demonstrated that overexpression of wild-type, but not the mutant, Jhdm1b resulted in 
marked decrease of H3K36me2 levels (Fig. 3-1E). Although a small decrease in H3K36me3, 
as well as H3K4me3 was observed, the minor decrease did not rely on a functional JmjC 
domain as it can also be seen in the cells over expressing the catalytic mutant. Given that 
overexpression of Jhdm1b in HeLa cells was previously reported to result in the decrease of 
H3K4me3 levels (Frescas, Guardavaccaro et al. 2007), we overexpressed Jhdm1b in HeLa 
cells by lentiviral infection. Western blot analysis of the histones purified from the infected 
HeLa cells confirmed our observation in the HEK293 cells (Fig. S3-3A). Taken together, our 
results indicate that Jhdm1b is an H3K36 rather than H3K4-specific demethylase.  
Jhdm1b knockdown inhibits cell proliferation and induces senescence 
We next explored the function of Jhdm1b in primary cells. Given that previous 
analyses of Jhdm1b tumor suppressor function had been carried out in transformed or 
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immortalized cell lines, we postulated that the paradoxical conclusions regarding the role of 
Jhdm1b in cancer might be due to the many genetic alterations necessary for the 
establishment of these cell lines. We therefore designed an shRNA that can target all three 
murine isoforms of Jhdm1b and introduced it into primary mouse embryonic fibroblast 
(MEF) cells by lentiviral infection (Jhdm1b KD). After selection, the knockdown efficiency 
(90%) was verified by qRT-PCR (Fig. 3-2A). Interestingly, stable knockdown of Jhdm1b 
resulted in a substantial decrease in cell proliferation (Fig. 3-2B), a phenotype reminiscent of 
that displayed by MEF cells with reduced levels of the Polycomb group protein Ring1b 
(Voncken, Roelen et al. 2003; Cales, Roman-Trufero et al. 2008). On the basis of this 
observation, shRNA directed against Ring1b was introduced into MEF cells (Ring1b KD), 
and knockdown efficiency was determined by RT-qPCR to be 90% (Fig. 3-2A). 
Furthermore, knockdown of Jhdm1b had no substantial effect on Ring1b levels and vice 
versa (Fig. 3-2A). Comparison of the cell proliferation levels of Ring1b KD, Jhdm1b KD, 
and control cells confirmed Ring1b’s drastic effects on cell proliferation and indicated that 
Jhdm1b knockdown, while drastic, did not achieve the same level of cell growth inhibition as 
that of Ring1b knockdown (Fig. 3-2B). BrdU pulse labeling followed by flow cytometry 
analysis revealed that Jhdm1b KD resulted in a 2-fold reduction in the number of cells in S-
phase as compared to control MEFs, while a 4-fold reduction is observed in the Ring1b KD 
cells (Fig. 3-2C). In addition, Ring1b has been demonstrated to play an important role in 
regulating cellular senescence as a component of the Polycomb repressive complex 1 (PRC1) 
which enacts negative regulation of the p16Ink4a locus (Jacobs, Kieboom et al. 1999; Cales, 
Roman-Trufero et al. 2008). To investigate whether Jhdm1b KD also contributes to pre-
mature cellular senescence, Ring1b and Jhdm1b KD MEFs were analyzed for the presence of 
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senescence-associated β-galactosidase (SA-β-galactosidase) at different passages. While only 
very few cells stained positive for SA-β-galactosidase in control MEFs at passage 5, Jhdm1b 
KD MEFs underwent cellular senescence at a markedly increased rate (Fig. 3-2D) while 
Ring1b knockdown had the most drastic ability to induce senescence. Taken together, these 
results suggest that Jhdm1b is involved in the positive regulation of cell cycle and negative 
regulation of passage-dependant cellular senescence. 
Jhdm1b regulates cell proliferation through p15Ink4b 
Cellular proliferation and senescence is tightly regulated through the p53 and pRb 
pathways, and both of these cellular pathways can be inhibited by the introduction of SV40 T 
antigen into primary cells (Goodrich, Wang et al. 1991). To determine whether the function 
of Jhdm1b in cell proliferation and senescence is pRb and p53 dependent, we inactivated 
both pathways by retroviral expression of SV40 large T antigen in MEFs and then subjected 
the cells to Jhdm1b knockdown. Knockdown of Jhdm1b does not alter the cellular 
proliferation of MEF cells when the p53 and pRB pathways are blocked by the SV40 large T 
antigen-transduced cells (Fig. S3-4A). Consistent with this result, the percentage of S-phase 
cells, as indicated by BrdU incorporation, is not altered by Jhdm1b knockdown under these 
conditions (Fig. S3-4B). In addition, Jhdm1b knockdown induced cellular senescence, as 
assessed by the appearance of SA-β-galactosidase staining, was also blocked in SV40 large T 
antigen-transduced cells (Fig. S3-4C). Collectively, these data suggest that Jhdm1b’s pro-
growth and anti-senescence properties act upstream of these two pathways.  
Previous studies have identified several genes whose expression is linked to Rb-
regulated cellular senescence and p53-dependant apoptosis (Sherr and Roberts 1999). These 
genes include members of the Ink4a/Arf/Ink4b tumor suppressor locus, p18 (also known as 
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Ink4c), and the cell cycle regulators p27 (also known as Cdkn1b) and p21. To determine 
whether loss of Jhdm1b function affected expression of any of these genes, we performed 
qRT-PCR in control, Jhdm1b KD, and Ring1b KD cells. Jhdm1b KD resulted in a marked 
upregulation of p15Ink4b (Fig. 3-3A). In agreement with the crucial role of Ring1b in the 
PRC1 complex, Ring1b KD resulted in a substantial upregulation of p16Ink4a (Jacobs, 
Kieboom et al. 1999; Cales, Roman-Trufero et al. 2008). In addition, we also observed a 
marked increase in p15Ink4b mRNA levels. The effect of Jhdm1b and Ring1b KD on p15Ink4b 
and p16Ink4a levels was also confirmed by Western blot (Fig. 3-3B). These data are consistent 
with the observation that the p16Ink4a protein has a more potent inhibitory effect on cell 
proliferation, as well as the notion that p15Ink4b functions to back-up the function of p16Ink4a 
(Krimpenfort, Ijpenberg et al. 2007). Importantly, similar to Ring1b KD, the expression of 
p21, a p53 pathway target gene, was not altered by Jhdm1b KD (Fig. 3-3A). To analyze 
whether p15Ink4b is a key mediator of Jhdm1b’s function in cellular proliferation, we derived 
primary MEFs from p15Ink4b null mice (Rosu-Myles, Taylor et al. 2007) and performed 
knockdown of Jhdm1b or Ring1b. Loss of p15Ink4b function could largely rescue the slow 
proliferation and low BrdU incorporation caused by Jhdm1b knockdown (Fig. 3-3C,D). 
Thus, we conclude that Jhdm1b regulates cellular proliferation and senescence by negatively 
regulating the expression of the p15Ink4b tumor suppressor gene in primary cells. 
Jhdm1b regulates p15Ink4b expression through H3K36 demethylation  
H3K36 methylation, which has been linked to active gene transcription in organisms 
from yeast to humans, is present within the coding regions of genes being actively 
transcribed, and tends to peak towards the 3’ end of transcribed regions (Bannister, Schneider 
et al. 2005; Martin and Zhang 2005; Morris, Shibata et al. 2005; Rao, Shibata et al. 2005). 
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The mechanism by which high levels of H3K36me2 are excluded from the promoter of 
active genes, as well as the functional significance of this observation is still not clear in 
higher eukaryotes. However, it has been demonstrated that SET2 association with elongating 
RNAPII is at least partly responsible for this phenomenon in yeast (Morris, Shibata et al. 
2005). To investigate whether the demethylase activity of Jhdm1b directly contributes to 
p15Ink4b regulation and cellular proliferation, we attempted to rescue the Jhdm1b KD MEFs 
with siRNA resistant wild-type F-Jhdm1b as well as catalytically deficient mutant, F-Jhdm1b 
(H211A). After confirming equal expression of the rescue constructs (Fig. S3-5), we 
analyzed their effects on cellular proliferation. Re-introduction of wild-type Jhdm1b rescued 
the growth defects, whereas re-introduction of the catalytically defective mutant did not (Fig. 
3-4A). In addition, re-introduction of wild-type Jhdm1b, but not the catalytic mutant, restored 
p15Ink4b expression to control levels (Fig. 3-4B). Thus, both normal cell proliferation and 
p15Ink4b repression depends on the demethylase activity of Jhdm1b.  
Having established that transcriptional repression of p15Ink4b depends on the H3K36-
demethylase activity of Jhdm1b, we used chromatin immunoprecipitation (ChIP) assays to 
decipher whether p15Ink4b is a direct target of Jhdm1b. Because none of the available Jhdm1b 
antibodies worked in immunoprecipitation in our hands, we resolved to retrovirally express 
F-Jhdm1b in primary MEF cells and performed ChIP assays using Flag antibodies. F-Jhdm1b 
was found to be specifically enriched 3-fold above background in regions just upstream 
(amplicon 1) and surrounding the transcription start site (amplicon 2) of p15Ink4b when 
compared with mock infected cells (Fig. 3-4C,D). However, the protein was not enriched 
within the p15Ink4b intron (amplicon 3) (Fig. 3-4C,D). ChIP analysis of H3K36me2 levels at 
these same regions in Jhdm1b KD and control cells revealed that KD of Jhdm1b resulted in 
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an increase in the H3K36me2 levels across the locus when compared to control cells (Fig. 3-
4E), suggesting that Jhdm1b might also play an active role in the demethylation of 
H3K36me2 downstream of the transcription start site. However, it has not escaped our 
attention that increased transcription of the gene may itself contribute to increases in 
H3K36me2 within the coding region. Furthermore, rescue of the KD by wild-type Jhdm1b 
resulted in H3K36me2 levels below those of control cells (Fig. 3-4E). In addition, 
H3K36me2 levels within the Gapdh locus were unchanged for all samples (data not shown). 
Taken together, these data suggest that p15Ink4b is a direct Jhdm1b target and that Jhdm1b 
regulates p15Ink4b expression through active demethylation of H3K36. 
Jhdm1b cooperates with Ras to induce oncogenic transformation 
All of the data presented above indicates that Jhdm1b functions as a proto-oncogene 
through its ability to repress transcription of the p15Ink4b locus. In an effort to further establish 
the oncogenic potential of Jhdm1b, we assessed the contribution of the protein to colony 
formation using knockdown or overexpression in p53 null MEFs followed by superinfection 
of retroviral H-Ras12V virus. Results of soft-agar colony formation analysis indicate that co-
expression of RAS and Jhdm1b in p53 null MEF cells results in an increase in Ras induced 
oncogenic transformation (Fig. 3-5A). Conversely, knockdown of Jhdm1b inhibited Ras-
induced colony formation (Fig. 3-5B). Together these data support the notion that Jhdm1b 
acts as a proto-oncogene in primary fibroblast cells. 
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DISCUSSION 
In this report, we demonstrate that Jhdm1b, like its paralogue Jhdm1a, functions as an 
H3K36 demethylase in vitro and in vivo. Recombinant Jhdm1b purified from baculovirus 
infected Sf9 cells demethylates H3K36me2 in vitro in a radioactive formaldehyde release 
assay and in histone Western blot analysis (Fig. 3-1) and Western blotting and ChIP analysis 
indicate that overexpression of Jhdm1b results in global H3K36me2 demethylation (Fig. 3-
1E), as well as gene-specific H3K36me2 demethylation (Fig. 3-4) in different cell types 
including HeLa and HEK293 cells (Fig. S3-3A). In addition, the previously suggested 
nucleolar staining pattern of Jhdm1b could not be observed in either HeLa cells (Frescas, 
Guardavaccaro et al. 2007) (Fig. S3-3B), or AD293 cells (Fig. S3-5B).  
In addition to the substrate specificity of Jhdm1b, its role in tumorigenesis has also 
been a point of contention. One of the earliest reports of Jhdm1b function came out of a 
genetic screen for tumor suppressor genes in mouse lymphomas (Suzuki, Minehata et al. 
2006). The authors identified several bi-allelic retroviral insertion events at the Jhdm1b locus 
when several of the induced lymphomas were analyzed. However, further analysis of 
additional tumor samples revealed locus insertion that left the Jhdm1b coding region intact. 
This leaves open the possibility that the tumor manifesting retroviral insertions could either 
activate or suppresses Jhdm1b function. Therefore, the potential of Jhdm1b to serve as an 
oncogene or tumor suppressor was not resolved in this study. In addition some indirect 
evidence suggested Jhdm1b may act as a tumor suppressor, including a link to the negative 
regulation of c-Jun (Koyama-Nasu, David et al. 2007), as well as a description of its role in 
the negative regulation of rRNA genes (Frescas, Guardavaccaro et al. 2007). However, these 
experiments were carried out in various cell lines in which critical pathways important for 
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cellular senescence and tumorigenesis (such as those regulated by Ink4a/Arf/Ink4b) are also 
disrupted. Thus further evidence would be required to support the relevance of previously 
identified gene targets in a normal context. A recent report that screened 44 random MMLV 
induced T cell lymphomas identified the Jhdm1b locus as an insertion hotspot (Pfau, Tzatsos 
et al. 2008). This study revealed multiple, orientated provirus insertions upstream of the 
canonical Jhdm1b promoter and further implicated a role for Jhdm1b overexpression in the 
immortalization of primary MEF cells.  
In this study, we provide several lines of evidence that support Jhdm1b may indeed 
be a proto-oncogene. First, we demonstrate in primary MEFs that knockdown of Jhdm1b 
resulted in cell proliferation defects and increased senescence (Fig. 3-2). Furthermore, we 
demonstrate that Jhdm1b contributes to the regulation of cell proliferation and senescence by 
directly repressing the expression of the p15Ink4b tumor suppressor (Figs. 3-3 & 3-4). 
Importantly, p15Ink4b appears to be a major target that mediates Jhdm1b function in cellular 
proliferation since loss of p15Ink4b function can largely rescue the Jhdm1b knockdown effects 
(Fig. 3-4).  Finally, Jhdm1b can cooperate with Ras to transform primary MEF cells (Fig. 3-
5). Therefore, we conclude that Jhdm1b is indeed a proto-oncogene which functions at least 
partially by controlling the expression of the p15Ink4b tumor suppressor through removal of 
H3K36me2. 
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EXPERIMENTAL PROCEDURES 
Cloning, cell line generation:  All of the cell lines used in this study were maintained in 
Dulbeccos’s modified Eagle’s medium supplemented with 10% (v/v) fetal bovine serum and 
1% (v/v) penicillin/streptomycin. Primary MEFs harvested from day 13.5 C57BL/6 and 
p15Ink4b null mouse embryos were plated into a P75 flask. The confluent cells were frozen 
down and considered passage 1. The cells were split at 1:5 for each passage. Cell growth was 
measured by plating 5x105 MEFs on a 100mm plate in triplicate for each group. The cell 
number was counted using a hemocytometer at the time points indicated. Selection and stable 
maintenance of exogenous plasmids was accomplished in the presence of either 1μg ml-1 
(AD293 cells) or 4μg ml-1 (MEF cells) puromycin. PCR amplification of an EST clone 
corresponding to full length Jhdm1B (NM_001003953) was cloned into a modified 
pFastBacHT B vector (Invitrogen) containing an N terminal flag epitope tag for baculovirus 
generation as per manufacturer’s protocol (Invitrogen). Full length Jhdm1B was subcloned 
into pMSCVpuro vector (Clontech) for stable cell line generation using the manufacturer’s 
protocol. Jhdm1b (H211A) mutant was generated by employing overlapping 
PCR/subcloning. Stable knockdown was achieved using a lentiviral system obtained from the 
NIH AIDS Research and Reference Reagent Program. The mouse U6 promoter was cloned 
from mouse genomic DNA and inserted into the NotI site of pTY-EF1a-nLacZ. For the LV-
U6 shRNA-Pgk-Pac construct, the Pgk-Pac cassette at NotI/EcoRI sites replaced the EF1a-
nLacZ cassette. The hairpin RNA targeting Jhdm1b (5’-GCTCCAACTCAGTTACTGT-3’), 
Ring1b (5’-GCAGTACACCATTTACATA-3’) and control (5’-
GTTCAGATGTGCGGCGAGT-3’) were cloned into BBSI/HindIII sties under the U6 
promoter (Cao, Wang et al. 2008). To generate wild type and mutant Jhdm1b (H211A) 
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rescue constructs, the siRNA target site of Jhdm1b was mutated to 
ATTGCAGTTGAGTTACTGT by PCR mutagenesis. The siRNA resistant wild type and 
mutant Jhdm1b cDNAs were PCR amplified and cloned into either SpeI/EcoRI site of LV 
vector or NotI/XbaI of RV vector.  
In vitro histone demethylase formaldehyde release assay:  Histone substrates were 
radiolabeled and formaldehyde release assays were performed as previously 
described(Zhang, Tamaru et al. 2002; Tsukada, Fang et al. 2006). Unless otherwise stated, 
5μg of Flag purified recombinant protein was incubated in the presence of labeled substrate 
corresponding to 60,000 input counts and demethylase buffer (50 mM HEPES-KOH (pH 
8.0), 70 mM Fe(NH4)2(SO4)2, 1 mM α-ketoglutarate, 2 mM ascorbate) for one hour at 37˚C. 
Released, labeled formaldehyde was extracted using a modified NASH technique and 
subjected to scintillation counting. Data is presented as counts per minute in the extracted 
sample. 
Western blot analysis and immunostaining:  Total protein was extracted by RIPA buffer. 
Purified native histones from HeLa cells or acid extracted histones from the indicated cell 
lines were prepared as previously described(Wang, Wang et al. 2004). Antibodies against 
specific methylation states were used at dilutions ranging from 1:250 – 1:1000: 
H3K36me1(Abcam 9048), H3K36me2(Tsukada, Fang et al. 2006) H3K36me3(Abcam 
9050), H3K4me1(Abcam 8895), H3K4me2 (Abcam 7766), H3K4me3(Abcam 8580). Blots 
were normalized using an antibody against pan H3 (Abcam 1791). Anti-p21(Santa Cruz SC-
397), anti-p15Ink4b (Cell Signaling 4822), and anti-p16Ink4a (Santa Cruz SC-1207) were used 
at dilution of 1:1000 for Western Blot. Indirect immunostaining was carried out using 
primary MEFs and Hela cells. The cells were plated onto cover slips in 6 well plates after LV 
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transduction, fixed 48 hours post transduction for 20 min in 4% (w/v) paraformaldehyde, 
washed with three times with PBS, and subsequently permeabilized for 20 min in 0.5% (v/v) 
Triton-X-100/PBS. Permeablized cells were blocked in 3% (w/v) BSA/PBS for 30min and 
incubated with Flag monoclonal M2 antibody (Sigma) at 1:1000 dilution in a humidified 
chamber for 3 hours. After incubation, cells were washed 3 times and incubated with FITC or 
Rhodamine conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) at 
dilution of 1:500. Cells were washed twice with PBS, stained with 4,6-diamidino-2-
phenylindole dihydrochloride (DAPI), and mounted on glass slides in fluorescence mounting 
medium (DAKO). Slides were analyzed on an Axiovert 200 fluorescent microscope (Zeiss).   
BrdU incorporation and cycle cycle analysis:  MEFs were grown in the presence of 10 μM 
BrdU for 60min. The cells were harvested and fixed overnight using 75% ethanol. Fixed cells 
were stained with FITC conjugated mouse anti-BrdU antibody (BD biosciences, 347583) and 
propidium iodide. The stained cells were analyzed by flow cytometry (BD FACSCalibur) 
and data was analyzed using WinMDI version 2.9 (TSRI flowcytometry Software). 
Senescence associated-β-galactosidase assay:  Cells were washed twice with PBS and 
immersed in fixation buffer (2% (w/v) formaldehyde, 0.2% (w/v) glutaraldehyde in PBS) for 
10 min. After two additional PBS washes the cells were allowed to stain overnight in staining 
solution (40 mM citric acid/sodium phosphate pH 6.0, 150 mM NaCl, 2.0 mM MgCl2, 1 mg 
ml-1 x-gal). 
Reverse transcription and qPCR:  RNA was extracted and purified from cell lines using 
Qiashredder (Qiagen) and RNeasy (Qiagen) spin columns; DNase treated (Promega RQ1 
Dnase) and cleaned up using Qiagen RNeasy column (Qiagen). 1μg of RNA was subjected to 
reverse transcription using random primers (Promega) and Improm-II reverse transcription 
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kit (Promega). cDNA levels were assayed via Real time PCR using SYBR GreenER 
(Invitrogen) and analyzed on an ABI 7300 Real Time PCR System with SDS software 
version 1.3.1. qRT-PCR primer sequences are available in Table 3-1. 
ChIP assay:  ChIP assays employing flag-antibody were carried out as previously reported 
(Zeng, Vakoc et al. 2006) with the following modifications: 20μl of M2 agarose (Sigma) was 
used in the immunoprecipitation and chromatin-bound beads were washed three times each 
in TSEI (0.1% [w/v] SDS, 1% [v/v] Triton-X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris 
[pH 8.1]) TSEII (0.1% [w/v] SDS, 1% [v/v] Triton-X-100, 2mM EDTA, 500 mM NaCl, 20 
mM Tris [pH 8.1]) and TSEIII (0.25M LiCl, 1% [v/v] NP-40, 1% [w/v] deoxycholate, 1mM 
EDTA, 10mM Tris [pH 8.1]) followed by two washes in TE. Histone modification ChIPs 
were carried out as previously reported(Cao, Tsukada et al. 2005). ChIP DNA was analyzed 
via qPCR and data are presented as percentage of input as determined using Applied 
Biosystems’s SDS software Absolute Quantification protocol. Primer sequences are available 
in Table 3-1. 
Soft agar colony assay:  p53 null MEFs were transduced with different LVs. 48 hours after 
transduction, the cells were superinfected with retroviral H-Ras12V virus. 5000 cells were 
mixed in the 0.35% (w/v) top agar and plated onto 0.5% (w/v) basal agar. 14 days after 
plating, the cells were stained with 0.005% (w/v) crystal violet and colony number was 
counted.  
Standard error reporting:  All in vitro formaldehyde release assays and cell based assays 
were performed in triplicate and error bars represent the standard deviation of three 
independent experiments. ChIP assays and qRT-PCR experiments were repeated at least 
twice and data is reported for one of the biological replicates. Error bars represent the 
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standard deviation of three qPCR reactions as determined by SDS 1.3.1 software (Applied 
Biosystems).  Soft agar colony assays were performed and error bars represent the standard 
deviation of large colony numbers between three separate plating replicates. 
  
 
Figure 3-1.  Jhdm1b is an H3K36-specific demethylase in vitro and in vivo. (A) In vitro 
formaldehyde release assay using histone substrates generated with the indicated 
methyltransferases and incubated with either recombinant Flag-Jhdm1b (empty bars) or no 
enzyme control (black bars). (B) In vitro formaldehyde release assay using recombinant 
Jhdm1b, Jhdm1b(H211A), JHDM1A and RBP2 incubated with H3K36-methylated (empty 
bars) or H3K4-methylated (black bars) substrates generated with SET2 or SET7(Y245A) 
methyltransferase, respectively. (C) HeLa cell core histones were incubated in the presence 
(+) or absence (-) of recombinant Jhdm1b. The resulting reaction was subjected to Western 
blotting with the indicated modification state-specific antibodies. (D) Jhdm1b mRNA levels 
from AD293 cells stably over-expressing F-Jhdm1b, F-Jhdm1b(H211A), or empty vector 
control cells. Samples were normalized relative to Gapdh and the Jhdm1b expression level in 
the empty vector control cells was arbitrarily set to 1. (E) Acid extracted histones were 
prepared from AD293 cells stably overexpressing F-Jhdm1b or F-Jhdm1b(H211A) and 
subjected to Western blotting using the indicated methyl-state specific histone antibodies.  
All error bars represent s.d. (n=3). 
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Figure 3-2.  Jhdm1b knockdown in primary MEFs inhibits cell proliferation and induces 
cellular senescence. (A) Primary MEFs at passage 1 were transduced with lentiviral control 
(black bars), Jhdm1b (Jhdm1b KD, grey bars) or Ring1b (Ring1b KD, empty bars) shRNA 
and further selected by puromycin for 48 hours. mRNA levels were determined by 
quantitative real-time PCR (qRT-PCR). Samples were normalized against levels of Gapdh. 
The Jhdm1b or Ring1b expression level in empty vector control cells was arbitrarily set to 1. 
(B) Primary MEF cells transduced at passage 1 with lentiviral control (diamonds), Jhdm1b 
(Jhdm1b KD, squares), and Ring1b (Ring1b KD, triangles) shRNA and further selected by 
puromycin for 48 hours. 5x105 cells were plated and cell number was counted at different 
time points using a hemocytometer. (C) Primary MEFs were prepared as in (B), pulse labeled 
with BrdU and stained with PI and FITC conjugated anti-BrdU antibody. The percentage of 
BrdU positive cells was determined by flow cytometry for control (black bars), Jhdm1b KD 
(grey bars) and Ring1b KD (empty bars). (D) Cells prepared as in (B) were split at 1:5 for 5 
passages and senescence associated β-galactosidase activity at pH 6.0 was determined by 
cellular staining.  Data is presented for passage 1 (P1) and passage 5 (P5) cells.  All error 
bars represent s.d. (n=3). 
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Figure 3-3.  Jhdm1b regulates cell proliferation through p15Ink4b. (A) Primary MEFs at 
passage 1 were transduced with lentiviral control (black bars), Jhdm1b (Jhdm1b KD, grey 
bars) and Ring1b (Ring1b KD, white bars) shRNA and further selected by puromycin for 48 
hours. The expression level of the indicated genes was determined by qRT-PCR. Samples 
were normalized against levels of Gapdh and the expression level of each gene in empty 
vector control cells was arbitrarily set to 1. (B) Total protein was collected from cells 
prepared as in (A) and subjected to Western Blot analysis using antibodies against p15Ink4b, 
p16Ink4a, p21 and tublin. (C) Primary MEF cells isolated from p15Ink4b null mice at passage 1 
were transduced with lentiviral control (diamonds), Jhdm1b (Jhdm1b KD, squares), and 
Ring1b (Ring1b KD, triangles) shRNA and further selected by puromycin for 48 hours. 
5x105 cells were plated and cell number was counted at different time points using a 
hemocytometer. (D) Primary MEFs were prepared as in (C), pulse labeled with BrdU and 
stained with PI and FITC conjugated anti-BrdU antibody. The percentage of BrdU positive 
cells was determined by flow cytometry for control (black bars), Jhdm1b KD (grey bars) and 
Ring1b KD (empty bars).  All error bars represent s.d. (n=3). 
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Figure 3-4.  Jhdm1b regulates cell proliferation and p15Ink4b expression in a histone 
demethylase activity-dependent manner. (A) Primary MEF cells were transduced with 
lentiviral vectors carrying control shRNA (diamonds), Jhdm1b shRNA (Jhdm1b KD, 
squares), and Jhdm1b shRNA with expression of F-Jhdm1b (Jhdm1b KD/F-Jhdm1b, circles) 
or F-Jhdm1b(H211A) (triangles). 5x105 cells were plated 48 hours after transduction and 
maintained in culture for 8 days. Cell number was counted using a hemocytometer at the 
indicated time points. (B) mRNA was collected from cells prepared as in (A) and qRT-PCR 
was carried out to determine p15Ink4a expression level in each sample. Samples were 
normalized against levels of Gapdh and the expression level of each gene in empty vector 
control cells was arbitrarily set to 1. (C) Schematic representation of the p15Ink4b locus in 
mouse indicating the genomic structure of the locus (exons demarcated by black boxes), as 
well as the location of the three amplicons studied in ChIP experiments. (D) ChIP experiment 
utilizing chromatin prepared from primary MEF cells transduced with retrovirus encoding F-
Jhdm1b (empty bars) or control virus (black bars) were carried out using antibody against 
Flag. F-Jhdm1b binding was assayed via qPCR at the three genomic regions depicted in (C). 
(E) ChIP experiment utilizing chromatin from primary MEFs prepared as in (A) was carried 
out using antibody specific for H3K36me2. H3K36me2 levels were assayed via qPCR at the 
three genomic regions depicted in (C). Error bars represent s.d. (n=3). 
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Figure 3-5.  Jhdm1b facilitates Ras induced neoplastic transformation. (A) Primary MEF 
cells were transduced with mock or F-Jhdm1b expressing lentiviral vector followed by 
superinfection with retroviral H-Ras12V. 5000 cells were plated on soft agar and analyzed 14 
days later.  Graph represents quantification of large colonies on H-Ras transduced plates. (B) 
Primary MEF cells were transduced with lentiviral vectors carrying control shRNA (Control 
shRNA) or Jhdm1b shRNA (Jhdm1b KD) followed by puromycin selection and retroviral H-
Ras12V transduction. 5000 cells were plated on soft agar and analyzed 14 days later. Graph 
represents quantification of large colonies on H-Ras transduced plates.  All error bars 
represent s.d. (n=3).  
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Figure S3-1.  Amino acid alignment of the JmjC domain of Jhdm1a and Jhdm1b reveals 
substantial homology and conservation of residues important for demethylase activity. α-
ketoglutarate and Fe(II) cofactor binding sites are indicated (blue and red, respectively). The 
location of the amino acid substitution resulting in the demethylase activity dead point 
mutant H211A is indicated in green. 
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Figure S3-2.  Coomassie staining of recombinant proteins used in the demethylase assays. 
Recombinant proteins purified from infected Sf9 cells was subjected to SDS PAGE 
separation followed by Coomassie staining. Proteins used in Fig. 3.1A  (A) and Fig. 3.1 B 
(B) are shown. 
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Figure S3-3.  Overexpression of Jhdm1b in HeLa cells results in a global decrease of 
H3K36me2, but not H3K4me3, levels. (A) Acid extracted histones and whole cell lysate 
were prepared from puromycin selected HeLa cells infected twice with lentivirus carrying F-
Jhdm1b. Histone extracts were subjected to Western blotting utilizing antibodies against 
histone H3, H3K36me2, and H3K4me3. Whole cell extract was probed for the presence of 
exogenous Jhdm1b using flag antibody. (B) Immunostaining of the exogenous F-Jhdm1b in 
transduced HeLa cells revealed a uniform nuclear staining pattern. 
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Figure S3-4.  Overexpression of SV40 large T antigen abrogates the cell proliferation, cell 
cycle and cellular senescence phenotype associated with Jhdm1b KD. (A) 5x105 primary 
MEF cells were plated after transduction at passage 1 with lentiviral SV40 large T antigen 
followed by superinfection with either lentiviral control (black diamonds) or Jhdm1b shRNA 
(Jhdm1b KD, red squares). Cells were allowed to proliferate for eight days and cell number 
was counted at the indicated time points using a hemocytometer. (B) Primary MEF cells 
were prepared as in (a), pulse labeled with BrdU, and stained with PI and FITC conjugated 
anti-BrdU antibody. The percentage of BrdU positive cells was determined by flow 
cytometry. (c) Cells were prepared as in (a) and maintained in culture for 8 passages (split 
1:5). The intracellular senescence associated β-galactosidase activity at pH 6.0 was stained at 
each passage and data is shown for passage 1 and passage 8 cells. 
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Figure S3-5.  Jhdm1b wild-type and mutant rescue constructs express similar levels of flag-
tagged protein. (A) Western blot analysis of exogenous F-Jhdm1b and mutant F-Jhdm1b 
(H211A) expression in Jhdm1b KD MEF cells. (B) Immunostaining of the exogenous F-
Jhdm1b and mutant F-Jhdm1b (H211A) expression in Jhdm1b KD MEF cells. 
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Table 3-1.  All primers sequences used in the experiments described in Chapter 3. 
Figure# Name Use Sequence 5’-3’ 
3-1D hmJHDM1B-5 RT-PCR GACTTGTCGGACGTGGAGGA 
3-1D hmJHDM1B-3 RT-PCR CACATGTTGTCCACCCAGTC 
3-1D, 3-2A, 3-3A GAPDH5 RT-PCR CATGGCCTTCCGTGTTCCTA 
3-1D, 3-2A, 3-3A GAPDH3 RT-PCR GCCTGCTTCACCACCTTCTT 
3-2A, 3-3A JHDM1b-5 RT-PCR ACGTGATCCGGCCACCGCCCATC 
3-2A, 3-3A JHDM1b-3 RT-PCR TTGGAGATGTTGGTCCAACTGAG 
3-2A, 3-3A Ring1b-5 RT-PCR TAGTGGAGCAGAAGATAATGG 
3-2A, 3-3A Ring1b-3 RT-PCR TCAACAGTGGCATTGCCTGAAG 
3-3A, 3-4B P15INK4b-5 RT-PCR ATGTTGGGCGGCAGCAGTGACG 
3-3A, 3-4B P15INK4b-3 RT-PCR ATCTCCAGTGGCAGCGTGCAG 
3-3A P16INK4a-5 RT-PCR TACCCCGATTCAGGTGATGATG 
3-3A P16INK4b-3 RT-PCR TAGCTCTGCTCTTGGGATTGG 
3-3A P19ARF-5 RT-PCR TGATGTTTGGAAGTCCAGCAG 
3-3A P19ARF-3 RT-PCR AATGTCCATGAGGTTCTGAGC 
3-3A P18-5 RT-PCR AACGTCAACGCTCAAAATGG 
3-3A P18-3 RT-PCR AGGCTGTGTGCTTCATAAGG 
3-3A P21-5 RT-PCR ATGTCCAATCCTGGTGATGTC 
3-3A P21-3 RT-PCR TCTCTTGCAGAQAGACCAATC 
3-3A P27-5 RT-PCR TGAGAGTGTCTAACGGGAGCC 
3-3A P27-3 RT-PCR TCTGACGAGTCAGGCATTTGGTC 
3-4D, E mink4b1-5 ChIP CCGCCTAGAGATCGAACTAGCC 
3-4D, E mink4b1-3 ChIP CGCTTTTGCAATTGACTGAC 
3-4D, E mink4b2-5 ChIP CACCGAAGCTACTGGGTCTC 
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3-4D, E mink4b2-3 ChIP CTGTGGCAGAAATGGTCCTT 
3-4D, E mink4b3-5 ChIP ATGTTCTAAGAGGCTTTGTTTCCA
3-4D, E mink4b3-3 ChIP CATTTGTGCATAGGAGATCAGG 
3-4E mgapdh-5 ChIP CCACCCAGAAGACTGTGGAT 
3-4E mgapdh-3 ChIP GGATGCAGGGATGATGTTCT 
 
REFERENCES 
Bannister, A. J., R. Schneider, et al. (2005). Spatial distribution of di- and tri-methyl lysine 36 of 
histone H3 at active genes. J Biol Chem 280(18): 17732-6. 
Bracken, A. P., D. Kleine-Kohlbrecher, et al. (2007). The Polycomb group proteins bind 
throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21(5): 
525-30. 
Cales, C., M. Roman-Trufero, et al. (2008). Inactivation of the polycomb group protein Ring1B 
unveils an antiproliferative role in hematopoietic cell expansion and cooperation with 
tumorigenesis associated with Ink4a deletion. Mol Cell Biol 28(3): 1018-28. 
Cao, R., Y. Tsukada, et al. (2005). Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox 
gene silencing. Mol Cell 20(6): 845-54. 
Cao, R., H. Wang, et al. (2008). Role of hPHF1 in H3K27 methylation and Hox gene silencing. 
Mol Cell Biol 28(5): 1862-72. 
Frescas, D., D. Guardavaccaro, et al. (2007). JHDM1B/FBXL10 is a nucleolar protein that 
represses transcription of ribosomal RNA genes. Nature 450(7167): 309-13. 
Gil, J. and G. Peters (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all 
for one or one for all. Nat Rev Mol Cell Biol 7(9): 667-77. 
Goodrich, D. W., N. P. Wang, et al. (1991). The retinoblastoma gene product regulates 
progression through the G1 phase of the cell cycle. Cell 67(2): 293-302. 
Jacobs, J. J., K. Kieboom, et al. (1999). The oncogene and Polycomb-group gene bmi-1 regulates 
cell proliferation and senescence through the ink4a locus. Nature 397(6715): 164-8. 
Kamb, A., N. A. Gruis, et al. (1994). A cell cycle regulator potentially involved in genesis of 
many tumor types. Science 264(5157): 436-40. 
Kannengiesser, C., S. Dalle, et al. (2007). New founder germline mutations of CDKN2A in 
melanoma-prone families and multiple primary melanoma development in a patient receiving 
levodopa treatment. Genes Chromosomes Cancer 46(8): 751-60. 
Klose, R. J., Q. Yan, et al. (2007). The retinoblastoma binding protein RBP2 is an H3K4 
demethylase. Cell 128(5): 889-900. 
Kotake, Y., R. Cao, et al. (2007). pRB family proteins are required for H3K27 trimethylation and 
Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. 
Genes Dev 21(1): 49-54. 
Koyama-Nasu, R., G. David, et al. (2007). The F-box protein Fbl10 is a novel transcriptional 
repressor of c-Jun. Nat Cell Biol 9(9): 1074-80. 
76 
Krimpenfort, P., A. Ijpenberg, et al. (2007). p15Ink4b is a critical tumour suppressor in the 
absence of p16Ink4a. Nature 448(7156): 943-6. 
Martin, C. and Y. Zhang (2005). The diverse functions of histone lysine methylation. Nat Rev 
Mol Cell Biol 6(11): 838-49. 
Morris, S. A., Y. Shibata, et al. (2005). Histone H3 K36 methylation is associated with 
transcription elongation in Schizosaccharomyces pombe. Eukaryot Cell 4(8): 1446-54. 
Ogawa, S., N. Hirano, et al. (1994). Homozygous loss of the cyclin-dependent kinase 4-inhibitor 
(p16) gene in human leukemias. Blood 84(8): 2431-5. 
Okuda, T., S. A. Shurtleff, et al. (1995). Frequent deletion of p16INK4a/MTS1 and 
p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 85(9): 2321-30. 
Ortega, S., I. Prieto, et al. (2003). Cyclin-dependent kinase 2 is essential for meiosis but not for 
mitotic cell division in mice. Nat Genet 35(1): 25-31. 
Pfau, R., A. Tzatsos, et al. (2008). Members of a family of JmjC domain-containing oncoproteins 
immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad Sci U 
S A 105(6): 1907-12. 
Rao, B., Y. Shibata, et al. (2005). Dimethylation of histone H3 at lysine 36 demarcates 
regulatory and nonregulatory chromatin genome-wide. Mol Cell Biol 25(21): 9447-59. 
Rosu-Myles, M., B. J. Taylor, et al. (2007). Loss of the tumor suppressor p15Ink4b enhances 
myeloid progenitor formation from common myeloid progenitors. Exp Hematol 35(3): 394-406. 
Sherr, C. J. and J. M. Roberts (1999). CDK inhibitors: positive and negative regulators of G1-
phase progression. Genes Dev 13(12): 1501-12. 
Suzuki, T., K. Minehata, et al. (2006). Tumor suppressor gene identification using retroviral 
insertional mutagenesis in Blm-deficient mice. Embo J 25(14): 3422-31. 
Tsukada, Y., J. Fang, et al. (2006). Histone demethylation by a family of JmjC domain-
containing proteins. Nature 439(7078): 811-6. 
Voncken, J. W., B. A. Roelen, et al. (2003). Rnf2 (Ring1b) deficiency causes gastrulation arrest 
and cell cycle inhibition. Proc Natl Acad Sci U S A 100(5): 2468-73. 
Wang, H., L. Wang, et al. (2004). Role of histone H2A ubiquitination in Polycomb silencing. 
Nature 431(7010): 873-8. 
Xiao, B., C. Jing, et al. (2003). Structure and catalytic mechanism of the human histone 
methyltransferase SET7/9. Nature 421(6923): 652-6. 
77 
78 
Zeng, P. Y., C. R. Vakoc, et al. (2006). In vivo dual cross-linking for identification of indirect 
DNA-associated proteins by chromatin immunoprecipitation. Biotechniques 41(6): 694, 696, 
698. 
Zhang, X., H. Tamaru, et al. (2002). Structure of the Neurospora SET domain protein DIM-5, a 
histone H3 lysine methyltransferase. Cell 111(1): 117-27. 
 
 
 
  
Chapter 4 
Genome wide uH2A localization analysis highlights Bmi1-dependent  
deposition of the mark at repressed genes 
 
  
ABSTRACT 
Polycomb group (PcG) proteins control organism development by regulating the 
expression of developmental genes. Transcriptional regulation by PcG proteins is achieved at 
least partly through the PRC2-mediated methylation on lysine 27 of histone H3 (H3K27) and 
PRC1-mediated ubiquitylation on lysine 119 of histone H2A (uH2A). As an integral 
component of PRC1, Bmi1 has been demonstrated to be critical for H2A ubiquitylation. 
Although recent studies have revealed the genome wide binding patterns of some of the 
PRC1 and PRC2 components, as well as the H3K27me3 mark, there have been no reports 
describing genome wide localization of uH2A. Using the recently developed ChIP-Seq 
technology, here we report genome wide localization of the Bmi1-dependent uH2A mark in 
MEF cells. Gene promoter averaging analysis indicates a peak of uH2A just inside the 
transcription start site (TSS) of well annotated genes.  This peak is enriched at promoters 
containing the H3K27me3 mark and represents the least expressed genes in WT MEF cells.  
In addition, peak finding reveals regions of local uH2A enrichment throughout the mouse 
genome, including almost 700 gene promoters.  Genes with promoter peaks of uH2A exhibit 
lower level expression when compared to genes that do not contain promoter peaks of uH2A.  
Moreover, we demonstrate that genes with uH2A peaks have increased expression upon 
Bmi1 knockout.  Importantly, local enrichment of uH2A is not limited to regions containing 
the H3K27me3 mark.  We describe the enrichment of H2A ubiquitylation at high density 
CpG promoters and provide evidence to suggest that DNA methylation may be linked to 
uH2A at these regions.  Thus, our work not only reveals Bmi1-dependent H2A ubiquitylation 
but also suggests that uH2A targeting in differentiated cells may employ a different 
mechanism from that in ES cells. 
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INTRODUCTION 
In higher eukaryotes, DNA is organized in the form of chromatin. The basic repeating 
unit of chromatin is called the nucleosome, which consists of 146 bp of DNA wrapped 
around a core histone octamer.  One unique feature of core histones is their proclivity for 
covalent modification including acetylation, methylation, ubiquitylation, and phosphorylation 
(Jenuwein and Allis 2001). In addition, DNA can be modified directly through methylation. 
These covalent modifications can affect gene transcription directly or indirectly through the 
recruitment of additional modulatory factors (Martin and Zhang 2005).  Therefore, different 
combinations of modifications on chromatin may ultimately determine distinct cellular states 
through regulating the transcriptional programs that cells adopt.  Thus, identification and 
characterization of the proteins that are responsible for the placement and maintenance of 
these epigenetic marks is of great importance in understanding cellular proliferation and 
differentiation.  
The addition of a single ubiquitin molecule to histone H2A at lysine 119 was first 
discovered over thirty years ago (Olson, Goldknopf et al. 1976). Classic experiments 
demonstrated that uH2A accounts for about 10% of total H2A (Levinger and Varshavsky 
1980).  Despite the knowledge of its existence, the identity of the responsible enzymes and 
the function of this modification have only recently begun to be elucidated. The first H2A 
ubiquitin E3 ligase was identified as the core components of the Polycomb repressive 
complex 1 (PRC1) composed of RING1/2, BMI1, and HPH2 (Wang, Wang et al. 2004).  
Biochemical and functional analysis of the PRC1 complex has revealed RING2/Ring1b as 
the catalytic subunit, which can be greatly stimulated by Bmi1 and Ring1a, as loss function 
on any of these two proteins resulted in drastic genome-wide reduction of uH2A (Cao, 
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Tsukada et al. 2005; Buchwald, van der Stoop et al. 2006). Genome-wide location studies 
revealed that PRC1 occupies the promoters of a subset of Polycomb repressive complex 2 
(PRC2) targets and both PRC1 and PRC2 are enriched at genes involved in developmental 
processes (Boyer, Plath et al. 2006; Bracken, Dietrich et al. 2006; Lee, Jenner et al. 2006).  
Recent studies have uncovered that Bmi1 homologs, such as Mel18 and NSPc1, can target 
the PRC1 complex in various cell types (Elderkin, Maertens et al. 2007; Wu, Gong et al. 
2008). In addition, a new E3 ligase for H2A, 2A-HUB, has also been reported (Zhou, Zhu et 
al. 2008) highlighting the fact that there must be Bmi1-dependent and Bmi1-independent 
pools of uH2A in the genome.  
Unlike PRC1, PRC2 possesses H3K27-specific histone methyltransferase activity 
(Cao and Zhang 2004).  The discovery that a component of PRC1, Pc, can specifically 
recognize and bind to H3K27me3 (Cao, Wang et al. 2002; Fischle, Wang et al. 2003; Min, 
Zhang et al. 2003) has prompted researchers to embrace a sequential recruitment model 
whereby PRC2-mediated H3K27 methylation contributes to PRC1 recruitment and 
subsequent ubiquitylation of histone H2A. This model is supported by three pieces of 
evidence.  First, studies on Hox and Ink4a/Arf loci indicate that PRC1 knockdown reduced 
local uH2A levels which correlate with upregulation of gene expression (Jacobs, Kieboom et 
al. 1999; Cao, Tsukada et al. 2005; Kotake, Cao et al. 2007).  Second, knockdown of the 
H3K27me3 demethylase, Utx, results in enrichment of both PRC1 and uH2A at PRC2 target 
genes (Lee, Villa et al. 2007).  Third, the majority of genome-wide Ring1b enriched regions 
in mouse embryonic stem cells (mES) co-localize with peaks of H3K27me3 (Ku, Koche et 
al. 2008). 
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In addition to the relationship between H3K27 methylation and H2A ubiquitylation, 
several studies also suggest a potential link between H3K27 methylation and DNA 
methylation. For example, H3K27 methylation has been demonstrated to play an important 
role in imprinted gene silencing (Lewis, Mitsuya et al. 2004; Umlauf, Goto et al. 2004).  
Components of PRC2, such as Ezh2, have been reported to interact with Dnmt1/3a/3b and 
are required for efficient DNA methylation at several target genes (Vire, Brenner et al. 2006). 
On the other hand, Dnmt1 may contribute to the recruitment of PRC1 as knockdown of 
Dnmt1 abrogates localization of PRC1 components to Polycomb bodies in cultured cells 
(Hernandez-Munoz, Taghavi et al. 2005).  Consistent with this notion, recent studies have 
demonstrated that components of PRC1 can interact with a methyl-DNA binding protein, 
Mbd1 (Sakamoto, Watanabe et al. 2007), and the Dnmt1-associated protein, Dmap1 
(Negishi, Saraya et al. 2007).  Despite these reports, a general correlation between H3K27 
methylation and DNA methylation may not exist as genome wide epigenetic profiling 
revealed only a small subset of H3K27me3 positive promoters were found to be 
hypermethylated (Fouse, Shen et al. 2008; Kondo, Shen et al. 2008).  Whether there exists a 
genome-wide link between PRC1 mediated H2A ubiquitylation and DNA methylation 
remains to be determined. 
The advent of chromatin immunoprecipitation coupled to genomic tiling arrays 
(ChIP-chip) has provided scores of reports highlighting genome wide maps of histone 
modifications (Barrera and Ren 2006), histone modifying enzyme binding profiles (Bracken, 
Dietrich et al. 2006), and transcription modulators (Kim, Abdullaev et al. 2007; Xu, Bieda et 
al. 2007).  Recent advances in ChIP-coupled deep sequencing have greatly expedited the 
tedious task of dissecting the interplay between epigenetic modifications and complex 
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transcriptional output (Schones and Zhao 2008).  Although genome-wide analysis of most 
epigenetic marks (Barski, Cuddapah et al. 2007; Mikkelsen, Ku et al. 2007; Wang, Zang et 
al. 2008), as well as transcription factors (Chen, Xu et al. 2008), has been reported for 
various cell lines, uH2A distribution remains a mystery.  In addition, the recent discovery 
that the majority of uH2A in the fly genome is placed by a complex containing the Bmi1 
homolog but lacking Pc (Lagarou, Mohd-Sarip et al. 2008) calls the generality of the 
sequential recruitment model into question.   
To understand how uH2A fits into the complex epigenetic architecture associated 
with mammalian chromatin, we describe the genome wide profile of Bmi1-dependent uH2A 
by comparing the enrichment of this mark in Bmi1 wild-type and null MEF cells. This 
analysis provides evidence that while Bmi1 dependent uH2A is enriched at genes containing 
the H3K27me3 mark, it is not limited to these regions.  In addition, analysis of genome-wide 
DNA methylation patterns reveals a link between uH2A and DNA methylation in high-
density CpG promoters. Transcription profiling of wild-type MEF cells indicates that Bmi1-
dependent uH2A is enriched at genes with low levels of de novo expression. Finally, genes 
containing the highest levels of Bmi1 dependent uH2A at their promoters are expressed 
higher upon Bmi1 loss of function than genes harboring low levels of uH2A. Thus, our study 
uncovers some previously unrecognized features of uH2A. 
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RESULTS 
Generating genome wide uH2A modification maps 
In an effort to understand the function of the Bmi1-dependent uH2A epigenetic mark, 
we performed chromatin immunoprecipitation (ChIP) experiments using the well 
characterized uH2A monoclonal antibody E6C5 (Vassilev, Rasmussen et al. 1995; de 
Napoles, Mermoud et al. 2004; Wang, Wang et al. 2004; Cao, Tsukada et al. 2005; Stock, 
Giadrossi et al. 2007) in wild-type MEFs. The precipitated DNA was subjected to deep 
sequencing using the Solexa sequencing technology.  As a control for non-specific 
background, and to focus the research on the Bmi1-dependent proportion of genomic uH2A, 
parallel ChIPs were also performed in Bmi1 null MEF cells.  A previous report has shown 
that these cells undergo drastic reductions in global H2A ubiquitylation (Cao, Tsukada et al. 
2005).  After sequencing 25 bp DNA fragments, the data retrieved from both cell types were 
mapped to the mm8 build of the Mus musculus genome.  DNA tags which did not uniquely 
map to the genome were discarded and the resulting tag libraries consisted of over 6 million 
and 8 million unique reads for the wild-type and Bmi1 null MEF cells, respectively.  We next 
performed normalization for the total number of uniquely mapped reads, and generated a 
final Bmi1-dependent uH2A summary file by aligning reads from both libraries and 
subtracting uH2A tags derived from Bmi1 null MEFs from those derived from wild-type 
MEFs.  Density maps were created by ignoring negative tag density regions (data not 
shown).  
Enrichment of uH2A at the majority of gene promoters is dependent on Bmi1 function 
Given the enrichment of many epigenetic marks at gene promoters, we began our 
analysis of Bmi1-dependent uH2A localization by examining the area directly surrounding 
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the transcription start site of well annotated genes.  To this end, the average per base pair 
normalized density of Bmi1-dependent uH2A was determined for a 10 kb region surrounding 
well annotated TSSs at a 200 bp resolution.  This genome wide averaging analysis revealed 
enrichment of the uH2A mark that peaked just inside the TSS (Fig. 4-1A).  Given the link 
between uH2A and PRC2 (Hernandez-Munoz, Taghavi et al. 2005), we next set out to 
determine if a quantitative relationship existed between Bmi1-dependent promoter uH2A 
enrichment and promoter H3K4me3 and/or H3K27me3 placement. To this end, well-
annotated genes were grouped into four classes based on the presence of H3K4me3 and 
H3K27me3 within their promoters, as determined by a previous study (Mikkelsen, Ku et al. 
2007).  The same averaging analysis was applied to these separate groups of genes which 
included promoters containing H3K4me3 only, H3K27me3 only, both H3K4me3 and 
H3K27me3 (bivalent), or lacking both modifications (no K4/no K27).  This analysis revealed 
Bmi1-dependent enrichment of average uH2A tag density for both the bivalent and 
H3K27me3 modified gene classes (Fig. 4-1B, compare grey line to green and blue lines).  
Enrichment manifested in an increase in averaged peak height, as well as an overall 
broadening of the uH2A peak further into the body of K27me3 marked genes.  This result is 
consistent with a role for PRC2 in the recruitment of PRC1 and subsequent ubiquitylation of 
histone H2A (Wang, Brown et al. 2004; Cao, Tsukada et al. 2005).  Interestingly, Bmi1-
dependent uH2A was still present at H3K4me3 genes at a level comparable to the all gene 
average (Fig. 4-1B, red line).  Furthermore, genes lacking both H3K4me3 and H3K27me3 
exhibited a depletion of uH2A tag density (Fig. 4-1B, purple line).  Together these gene 
region averaging results reveal an overall enrichment of Bmi1-dependent uH2A at gene 
promoters which is biased towards genes marked by H3K27me3.  
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Bmi1-dependent uH2A are enriched at specific genomic regions 
To complement the genome wide averaging studies described above, the uH2A tag 
library of wild-type MEFs was subjected to peak enrichment analysis using the TIROE 
program (Ho, Jothi et al. 2009) with the uH2A tag library derived from Bmi1 null MEFs set 
as background.  This data processing allowed us to identify the most enriched Bmi1-
dependent peaks of uH2A throughout the genome.   
The TIROE program identified 16,406 peaks of Bmi1-dependent uH2A throughout 
the genome with enrichment P values of at least 1e-5.  We began our analysis of peak 
distribution by roughly dividing the genome into genic and non-genic regions as determined 
by the presence of transcribed regions annotated in the REFSEQ database.  Interestingly, 
while genic regions correspond to only about 47% of the genome, they harbored 52% of the 
identified peaks (Table 4-1).  Further division of the genic regions of the mouse genome into 
promoter and transcribed regions revealed that peak number enrichment was present in both 
of these sub-groups with 671 peaks (4.1%) falling within gene promoters and the remaining 
7415 peaks (47.3%) localizing elsewhere along the transcribed body of the gene (Table 4-1).  
Distribution analysis of defined peaks along transcribed regions revealed an increased 
tendency of uH2A peak localization towards the transcription termination site of genes (Fig. 
S4-1A).  However, in agreement with tag library averaging data presented in Figure 4-1A, 
peaks that fell within the promoter of genes (defined as -1 kb to +1 kb around TSSs) 
exhibited an average tag density higher than those lying within gene bodies (Fig. S4-1B).  
Taken together, these data indicate that peaks of Bmi1-dependent uH2A are enriched within 
the transcribed regions of well-annotated genes with smaller peaks clustered towards the 
transcription termination site and larger peaks specifically occupying gene promoters. 
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Given the enrichment of tag density at gene promoters as visualized by both genome-
wide averaging (Fig. 4-1A) and peak localization (Table 4-1 & Fig. S4-1B), we next selected 
several representative TIROE peaks that localized within gene promoters to be verified by 
ChIP-qPCR.  ChIP assays were carried out in both wild-type and Bmi1 null MEFs using 
antibodies against uH2A and Bmi1.  The Bmi1 null subtracted tag density profiles 
surrounding the TSS of Cebpa, B4galnt1, Gfod2, Zfp12, Fgf6, Dcxr, Iars, Arpc3 and Chmp2a 
are shown in Figure 2A.  These peaks have TIROE enrichment P values of 2.4e-15, 1.2e-14, 
1.3e-12, 7.0e-11, 9.2e-09, 1.1e-08, 1.1e-07, 2.2e-06, and 3.0e-06, respectively.  ChIP assays 
not only confirmed the enrichment of uH2A at these loci in wild-type cells as compared to 
Bmi1 null cells, but also the presence of Bmi1 at these same regions in wild-type cells (Fig. 
4-2B).  Similar enrichment of uH2A and Bmi1 localization was not detected within the 
promoters of Mta2, Hbb2, and Ppara; genes which do not contain peaks of the uH2A 
epigenetic mark (Fig. 4-2B). 
Peaks of Bmi1-dependent uH2A overlap with other epigenetic marks 
Genetic studies have revealed a link between PRC1-catalyzed H2A ubiquitylation and 
PRC2-catalyzed H3K27 methylation. Biochemically, H3K27me3 has been shown to serve as 
a binding site for the recruitment of the PRC1 complex (Fischle, Wang et al. 2003; Min, 
Zhang et al. 2003).  These studies suggest that there should be a link between uH2A and 
H3K27me3. However, recent evidence from Drosophila has implicated another Bmi1 
containing complex, dRAF, in H2A ubiquitylation.  Interestingly, this complex lacks Pc and 
must utilize an alternative means of targeting (Lagarou, Mohd-Sarip et al. 2008).  To 
examine whether our dataset could shed light on the relationship between the two 
modifications, we investigated the overlap between peaks of Bmi1-dependent uH2A, 
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H3K27me3, and H3K4me3.  We reasoned that if an alternate method of E3 ligase 
recruitment was present in MEF cells then uH2A enrichment would be present in regions not 
marked by H3K27me3.  Of the 4132 peaks of H3K27me3 identified in a previous study 
(Mikkelsen, Ku et al. 2007), about 15% (651) overlap with peaks of uH2A.  Furthermore, 
about 11% of the 2,604 genomic regions defined as bivalent overlap with our uH2A dataset.  
Interestingly, about 5.6% of the 14,178 peaks of H3K4me3 exhibit co-localization with peaks 
of Bmi1-dependent uH2A.  Together, these findings reveal that enriched regions of uH2A 
show a marked localization bias to genomic regions which also contain the H3K27me3 mark.  
However, they also indicate that the vast majority of Bmi1-dependent uH2A falls outside of 
regions containing this mark and suggests that an alternate method of ubiquitin E3 ligase 
recruitment may exist in MEF cells.   
Given that about half of all uH2A enriched regions in the genome fall outside of 
genic regions and only 4% are localized to gene promoters (Table 4-1), we next explored 
possible differences between promoter and non-promoter peaks of uH2A with regards to 
H3K4me3 and H3K27me3 overlap.  To this end, peaks were binned by their localization 
inside or outside of promoters, and the number of peaks from each of these groups which 
overlapped with additional epigenetic modifications was calculated.  This analysis revealed 
that a higher proportion of promoter bound Bmi1-dependent uH2A peaks co-localized with 
either H3K4me3 or H3K27me3 when compared to peaks located outside of promoter regions 
(Fig. 4-3A).  This result is not surprising given the relative enrichment of H3K4/H3K27 
within gene promoter regions.  However, this finding reinforces the fact that Bmi1-dependent 
uH2A is distinct from the H3K27me3 mark with respect to the extent of its enrichment 
outside of genic regions.   
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We next investigated the local tag density of uH2A peaks both within and outside of 
promoters.  Results presented in Figure 4-3B show that on average, peaks of uH2A localized 
within gene promoters are composed of significantly more tags than peaks lying outside of 
gene promoters (Wilcoxon P value = 2.2e-3).  In addition, further sub-division of promoter 
and non-promoter peaks by H3K4me3 and H3K27me3 overlap reveals two additional pieces 
of information.  First, promoter specific enrichment of uH2A peak tag density occurs at 
genes that also contain the H3K27me3 mark (Fig 4-3C, compare promoter peak data sets).  
This result is consistent with whole genome averaging analysis presented in Figure 4-1B.  
Second, there is a depletion of average peak tag density at non-promoter regions that do not 
contain either H3K4me3 or H3K27me3 (Fig 4-3C, compare non-promoter peak data sets).  
This finding, in conjunction with the fact that the vast majority of non-promoter uH2A falls 
outside of H3K4me3 and H3K27me3 regions (Fig. 4-3A), suggests that the contribution of 
these independent peaks is driving overall depletion of tag density at non-promoter regions.  
Promoter bound uH2A is genetically linked to DNA methylation 
Previous studies indicate that PRC2 facilitates recruitment of DNA 
methyltransferases to at least a sub-set of Polycomb target genes (Vire, Brenner et al. 2006).  
This finding, together with the relationship between DNA methylation and transcriptional 
repression prompted us to investigate a possible link between genome-wide promoter uH2A 
and DNA methylation.  To this end, we first analyzed uH2A localization in relation to CpG 
dinucleotide content surrounding the TSS of known genes.  Following a previous 
characterization (Mikkelsen, Ku et al. 2007), we divided the genes into three groups defined 
as high level (n = 10,310), intermediate level (n = 2889), and low level (n = 2668) based on 
the density of CpGs within their promoter regions (HCP, ICP, and LCP, respectively).  We 
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repeated whole genome promoter averaging analysis and found that the promoter tag density 
of uH2A is strongly enriched at genes defined as HCP when compared to both ICP and LCP 
genes (Fig. 4-4A).  Recent reports have used bisulphite treatment coupled with deep 
sequencing to characterize the extent of DNA methylation at HCP group genes in ES, NPC, 
and MEFs (Meissner, Mikkelsen et al. 2008).  Comparison of the available DNA methylation 
data with our promoter uH2A peaks revealed a correlation between DNA methylation levels 
and average uH2A tag density in the HCP group (Fig. 4-4B).  Specifically, HCP genes with 
promoter peaks of Bmi1-dependent uH2A had higher levels of average DNA methylation 
when compared to HCP genes without uH2A peaks (Wilcoxon P value = 0.0426). 
To further characterize this correlation we asked whether the two modifications are 
genetically connected. Toward this end, we asked whether loss of DNA methylation would 
cause alteration in H2A ubiquitylation. A comparison of the uH2A levels in Dnmt1 null 
MEFs (Jackson-Grusby, Beard et al. 2001) revealed that loss of DNA methylation resulted in 
a significant decrease in uH2A levels (Fig. 4-4C). To determine whether alteration in uH2A 
level affects DNA methylation, we compared the DNA methylation levels in wild-type and 
Bmi1 null MEFs by cytosine extension analysis.  This technique takes advantage of DNA 
methylation sensitive/insensitive restriction enzymes and allows for the relative 
quantification of DNA methylation through end-labeling of genomic DNA digestion products 
(Fujiwara and Ito 2002). Results shown in Figures 4-4D and 4-4E revealed a small, but 
statistically insignificant difference in the DNA methylation levels in the wild-type and Bmi1 
null MEFs as determined by Student’s t-test. As expected, parallel analysis revealed a drastic 
decrease of DNA methylation in the Dnmt1 null MEFs as indicated by the increased 
sensitivity of genomic DNA to the methylation sensitive restriction enzyme, HpaII (Fig. 4-
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4D, E).  Taken together, these data not only revealed a correlation between promoter bound 
uH2A and HCP promoter DNA methylation, but also provide evidence that DNA 
methylation may be upstream of H2A ubiquitylation.  
Bmi1-dependent promoter uH2A marks repressed genes through its co-localization with the 
H3K27me3 mark  
Recent studies suggest a role for uH2A in the repression of developmental genes 
(Cao, Tsukada et al. 2005; Bracken, Dietrich et al. 2006; Kim, Paylor et al. 2006).  In 
addition, studies utilizing in vitro assembled chromatin templates have implicated uH2A in 
the repression of transcription initiation (Nakagawa, Kajitani et al. 2008). To determine 
whether Bmi1-dependent uH2A is a general indicator of transcriptional activity, we asked 
whether uH2A levels and gene expression levels have a general correlation. To this end, we 
profiled gene expression in wild-type MEFs using the Affymetrix Mouse Genome 430 2.0 
microarray and analyzed the relationship between presence of uH2A peaks and gene activity 
for 13,354 genes. Based on their expression level, genes were grouped into 10 equal sized 
bins and were correlated with promoter uH2A enrichment levels using genome-wide tag 
density averaging. This analysis revealed that while the peak height of uH2A enrichment did 
not change much over these expression groups, the lowest expressed gene groups exhibited a 
broadening of the average uH2A tag density peak into the body of genes (Fig. 4-5A).  To 
better visualize this trend, the region spanning from +0.6 kb to +2.0 kb of genes was 
reanalyzed with genes divided into 4 groups.  The resulting plot (Fig. 4-5B) confirms Bmi1-
dependent tag density broadening for genes present within the lowest expressed gene groups, 
a medium range broadening for genes in the third group, and no tag density broadening for 
the highest expressed genes present within the fourth group.   
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We next turned our attention to distinct promoter peaks of uH2A in an effort to 
understand gene specific outcomes as related to epigenetic mark deposition.  In agreement 
with the data described above, expression level averaging of genes containing promoter 
peaks of uH2A revealed them to be significantly lower expressed then those without uH2A 
peaks (Wilcoxon P value = 9.8e-3) (Fig. 4-5C).  Taken together, these data indicate that an 
overall increase in Bmi1-dependent uH2A abundance can be found at silenced or low 
expressed genes; likewise, genes marked by promoter peaks of uH2A tend to be expressed at 
a lower level then genes lacking peaks of Bmi1-dependent uH2A. 
The correlation between increased levels of uH2A and gene repression could be due 
to an intrinsic repressive effect of uH2A on transcription or due to an association of uH2A 
with other silencing epigenetic marks.  To differentiate between these possibilities, we 
compared genes with promoter uH2A enrichment peaks to those without peaks in terms of 
their association with promoter H3K4me3 or H3K27me3 marks. This analysis revealed that a 
higher proportion of genes containing uH2A are also marked by H3K27me3 either alone or 
in the context of bivalent domains when compared with genes not marked by uH2A (Fig. 4-
5D).  In addition, the uH2A positive gene set is enriched for promoters lacking both 
H3K27me3 and H3K4me3 as well as depleted for the H3K4me3 mark alone (Fig. 4-5D).  
This indicates that grouping genes based on uH2A results in a population enriched for 
epigenetic marks tightly linked to gene repression and depletion of epigenetic marks tightly 
linked to gene expression.  Given that this proportional shift could indicate that uH2A is 
passively correlated to gene repression, we next asked the question whether uH2A could 
function in conjunction with these additional epigenetic marks to fine-tune mRNA 
expression levels.  To this end, we repeated the analysis described in Figure 4-5C for uH2A 
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gene groups further sub-divided by additional promoter modifications and compared the 
average expression of these gene groups across classes (Fig. 4-5E).  Results confirm higher 
average expression of genes marked by H3K4me3 and drastically lower expression levels of 
genes containing promoter H3K27me3, H3K27me3 and H3K4me3 (bivalent), and neither 
mark (Fig. 4-5E).  Co-occurrence of uH2A with H3K4me3, H3K27me3, or bivalent domains 
did not result in any changes of average expression level when compared to genes harboring 
only the K4/K27 combinations.  The sole significant change in WT expression level was a 
small increase for genes containing only the uH2A mark (Wilcoxon P value = 0.026) (Fig. 4-
5E).  These results indicate that the correlation that exists between promoters bound by 
Bmi1-dependent uH2A and low level de novo gene expression is due to a proportional shift 
in other epigenetic marks that have a more profound effect on transcriptional state. 
Even though Bmi1-dependent promoter uH2A is enriched at silenced genes, results of 
de novo expression analysis in wild-type cells were not able to ascertain an active function 
for uH2A in gene silencing. It is possible that a global role for uH2A in gene silencing was 
masked in this analysis by the presence of other epigenetic modifications which are more 
potent in enacting transcriptional control.  To directly address a potential global role for 
Bmi1-dependent uH2A in gene silencing, we turned our attention to expression changes upon 
Bmi1 knock-out.  To this end, we performed a microarray study on Bmi1 null MEFs and 
compared gene expression with that in the wild-type MEFs.  Of the 671 genes marked by 
promoter uH2A, we were able to generate reliable fold-change transcription data for 472 
genes.  We found that on average, this group was upregulated in Bmi1 null MEF cells by 1.5 
fold.  We next investigated whether the level of uH2A loss at genes in Bmi1 null cells was 
correlated to increased expression upon Bmi1 knock-out.  For this analysis, genes containing 
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Bmi1-dependent peaks of uH2A were sorted into three groups by increasing tag density (n = 
157, 157, and 158, respectively), and both the average fold change as well as the data 
distribution of each group was determined.  Interestingly, genes marked by the lowest levels 
of uH2A exhibited the smallest average increase in transcription upon Bmi1 knock-out when 
compared to both intermediate and high tag density groups (1.14, 1.98, and 1.37 fold, 
respectively).  In addition, data distribution analysis and Wilcoxon signed-rank testing 
reveals that this finding is statistically significant (Fig. 5F).  Taken together, these data are 
consistent with a global role for Bmi1-dependent uH2A in gene silencing and extend gene 
specific analysis at important developmental regulators to genome-wide correlation. 
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DISCUSSION 
Deep sequencing techniques have recently been used to map epigenetic marks in high 
definition throughout mammalian genomes (Barski, Cuddapah et al. 2007; Mikkelsen, Ku et 
al. 2007; Meissner, Mikkelsen et al. 2008).  Even though mono ubiquitylation of H2A was 
one of the first histone modifications identified (Olson, Goldknopf et al. 1976), it remains 
among the least understood. Using a ChIP-seq approach, here we analyzed the genome-wide 
distribution of Bmi1-dependent uH2A. This investigation revealed several interesting 
features of this epigenetic modification which serve as the basis for further studies.  
Bmi1-dependent uH2A distribution throughout mammalian chromatin  
By combining genome averaging and peak localization analyses, this study reveals 
the first picture of the genome-wide localization of the uH2A mark and identifies Bmi1-
dependent enrichment within both genic and non-genic regions of the mouse genome.  On 
average, uH2A tag density is enriched at gene promoter regions (Fig. 4-1A) with further 
enrichment at genes marked by H3K27me3 (Fig. 4-1B).  Peak analysis reveals that Bmi1-
dependent uH2A enriched regions coincide with gene promoters at a much higher rate than 
can be expected by chance (Table 4-1), and these peaks encompass significantly higher tag 
values when compared with non-promoter peaks (Fig. 4-3B).  In addition, promoter peak tag 
values are enriched at genes also marked by H3K27me3 (Fig. 4-3C).  Interestingly, the gross 
distribution of genic uH2A peaks is skewed towards the 3’ end of genes, indicating that more 
regions of uH2A enrichment are found within these genic regions (Fig. S4-1A).  However, 
these peaks represent lower enrichment regions when compared to promoter peaks (Fig. S4-
1B).  Together, these data support the notion that H3K27me3 can contribute to the 
recruitment of PRC2 and ubiquitylation of H2A in promoters (Fischle, Wang et al. 2003; 
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Min, Zhang et al. 2003).  However, even though the highest regions of Bmi- dependent 
uH2A enrichment are at H3K27me3 genes, clear peaks also exist at genomic regions (both 
genic and non-genic) that do not contain this mark.  This uH2A distribution pattern is very 
different from what would be expected given a recent study of Ring1b and Bmi1 binding 
profiles in mES cells (Ku, Koche et al. 2008) but are more consistent with a previous study 
which described a proportion of gene promoters positive for Ring1b/Bmi1 but negative for 
PRC2 binding (Boyer, Plath et al. 2006).  Although this discrepancy may reflect the 
differences of uH2A distribution in ES cells and MEF cells, it is possible that similar to the 
observations in Drosophila (Lagarou, Mohd-Sarip et al. 2008), a Pc independent mechanism 
of Ring1b/Bmi1 recruitment may exist in MEF cells.  Along these lines, about half of all the 
most enriched Bmi1-dependent uH2A regions lie outside of both promoter and transcribed 
regions of the genome (Table 4-1).  Interestingly, these regions do not overlap significantly 
with peaks of H3K27me3. 
Relationship between uH2A and DNA methylation 
Since the initial finding linking Polycomb silencing to DNA methylation (Vire, 
Brenner et al. 2006), genome wide studies have called the generality of this association into 
question as very little overlap exists between genes methylated at H3K27 and genes that 
contain high levels of CpG island methylation associated with their promoters (Farthing, Ficz 
et al. 2008; Fouse, Shen et al. 2008; Kondo, Shen et al. 2008).   Recently, several reports 
have demonstrated a role for PRC1 in recognizing methylated DNA at specific loci or 
heterochromatic regions (Hernandez-Munoz, Taghavi et al. 2005) either through Bmi1 
interaction with Dmap1 (Negishi, Saraya et al. 2007) or Ring1b interaction with Mbd1 
(Sakamoto, Watanabe et al. 2007).  However, whether these specific instances of 
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convergence of silencing pathways are linked to global gene regulation has not been 
determined.  Here we provide evidence to support a functional link between DNA 
methylation and histone ubiquitylation through Bmi1-dependent mechanisms in a group of 
high CpG-containing genes.  Not only does the level of DNA methylation increase at HCP 
promoters marked by uH2A (Fig. 4-4B), a result that may be explained by an increase in 
H3K27 methylation on these genes, but knock-out of Dnmt1, which results in the ablation of 
CpG methylation genome wide, causes a global decrease in the uH2A levels (Fig. 4-4C).  In 
contrast, Bmi1 knock-out results in only a small, statistically insignificant, increase in global 
DNA methylation (Fig. 4-4D).  Taken together, these data suggest that DNA methylation 
may be upstream of Bmi1-dependent H2A ubiquitylation. Future work will reveal how DNA 
methylation contributes to H2A ubiquitylation. 
The relationship between uH2A and gene expression 
Recent studies in a limited gene set indicate that uH2A is mostly linked to 
transcriptional repression (Cao, Tsukada et al. 2005; Osley, Fleming et al. 2006; Stock, 
Giadrossi et al. 2007; Nakagawa, Kajitani et al. 2008).  Consistent with these studies, our 
genome-wide analysis indicate that Bmi1-dependent uH2A exhibits a broad enrichment at 
the most repressed genes in the mouse genome (Fig. 4-5A,B).  Peak centered analysis of 
promoter uH2A confirms this result (Fig. 4-5C) and reveals that this enrichment is most 
likely a consequence of over-representation of the H3K27me3 mark (Fig. 4-5C, D & E).  
These results indicate that unlike H3K27me3 (Barski, Cuddapah et al. 2007; Mikkelsen, Ku 
et al. 2007), uH2A by itself is not an accurate predictor of de novo expression levels and 
could serve to explain earlier studies which have reported the presence of uH2A at actively 
transcribed genes (Levinger and Varshavsky 1982; Barsoum and Varshavsky 1985).  Instead, 
98 
  
our results suggest that uH2A plays a much more refined role in the control of gene 
expression.  Analysis of expression changes in Bmi1 knockout MEFs revealed that, on 
average, genes marked by promoter peaks of uH2A are upregulated upon Bmi1 knockout.  In 
addition, the level of enrichment of these promoter uH2A peaks, as indicated by sequence tag 
density, reveal a clear increase in average fold change when higher density peaks are 
compared with lower density peaks (Fig. 4-5F).  Thus, our work extends gene specific 
studies and confirms the existence of a genome wide link between uH2A and gene silencing. 
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EXPERIMENTAL PROCEDURES 
Cell Lines, Cell Culture, and Antibodies:  Mouse embryonic fibroblast cells were isolated 
from Bmi1 null and Bmi1 wild-type littermates and immortalized by expression of the 
TBX2.pBabePURO construct (Jacobs, Keblusek et al. 2000).  Both cell lines were 
maintained in Dulbecco’s modified Eagles Medium supplemented with 10% (v/v) fetal 
bovine serum and 1X Penicillin/Streptomycin.  Antibodies employed in this study are as 
follows: α-uH2A (Millipore, 05-678), α-Bmi1 (Millipore, 05-637), and α-H3(Abcam, 1791). 
Chromatin Immunoprecipitation Assays:  ChIP assays were performed as previously 
described (Cao, Tsukada et al. 2005) with the following alterations.  Chromatin was prepared 
from one 15 cm2 plate grown to 95% confluence.  After nuclei isolation, the pellet was 
resusupended in Solution B (20mM Hepes pH 7.9, 25% [v/v] glycerol, 0.5% [v/v] NP-40, 
0.42M NaCl, 1.5mM MgCl2, 1mM CaCl), subjected to sonication, and then treated with 30 
units of micrococcal nuclease for 15 minutes to ensure mononucleosome resolution. 
Immunoprecipitations were carried out using 15 µg of antibody.  For qPCR detection, the 
percent of IP enrichment as compared to input was calculated for both WT and Bmi1 null 
ChIPs using SYBR GreenER (Invitrogen) and data is presented as the fold change in percent 
input of WT versus Bmi1 null cells.  All detection primers are listed in Table 4-2. 
Solexa sequencing:  Immunoprecipitated DNA fragments were blunt-ended, ligated to Solexa 
adaptors and sequenced using the Illumina 1G Genome Analyzer as previously 
described(Barski, Cuddapah et al. 2007).   
Sequence mapping:  The 25 bp sequenced reads were obtained and mapped to the mouse 
genome (mm8 assembly) using the Solexa Analysis Pipeline, as previously described (Barski, 
Cuddapah et al. 2007).  This yielded a BED file containing a total of 6.1 and 8.0 million 
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unique tags for Bmi1 wild-type, and Bmi1 null libraries, respectively. Summary files were 
then created for each library by counting the number of tags falling into 200 bp genomic 
bins.  A Bmi1-dependent uH2A summary file was created by applying a scaling factor to the 
WT file to equalize total tag count and subtracting the Bmi1 null tag count from the WT tag 
count within each genomic bin.  The raw and processed sequencing and microarray data has 
been deposited in the NCBI Gene Expression Omnibus (GEO) under accession number 
GSE15909.  
Expression microarray experiments:  7 μg of total RNA from both Bmi1 wild-type and null 
MEFs was used to synthesize cDNA.  A custom cDNA kit from Life Technologies was used 
with a T7-(dT)24 primer for this reaction.  Biotinylated cRNA was then generated from the 
cDNA reaction using the BioArray High Yield RNA Transcript Kit.  The cRNA was then 
fragmented in fragmentation buffer (5X fragmentation buffer: 200mM Tris-acetate, pH8.1, 
500mM KOAc, 150mM MgOAc) at 94oC for 35 minutes before the chip hybridization.  15 
μg of fragmented cRNA was then added to a hybridization cocktail (0.05 μg μl-1 fragmented 
cRNA, 50 pM control oligonucleotide B2, BioB, BioC, BioD,  and cre hybridization controls, 
0.1 mg ml-1 herring sperm DNA, 0.5 mg ml-1 acetylated BSA, 100mM MES, 1M [Na+], 
20mM EDTA, 0.01% [v/v] Tween 20).  10 μg of cRNA was used for hybridization.  
Affymetrix Mouse Genome 430 2.0 Arrays were hybridized for 16 hours at 45oC in the 
GeneChip Hybridization Oven 640.  The arrays were washed and stained with R-
phycoerythrin streptavidin in the GeneChip Fluidics Station 400.  After this, the arrays were 
scanned with the Hewlett Packard GeneArray Scanner.  Affymetrix GeneChip Microarray 
Suite 5.0 software was used for washing, scanning, and basic analysis.  Sample quality was 
assessed by examination of 3’ to 5’ intensity ratios of certain genes. 
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Cytosine Extension:  The assay was adapted from a previous report (Fujiwara and Ito 2002).  
Briefly, 100 ng of genomic DNA was digested to completion using MspI and HpaII 
(Fermentas) and the result was subjected to single nucleotide extension in the presence of 
biotin-labeled dCTP (Invitrogen).  One-fiftieth of the final reaction was manually spotted on 
(+) nylon membrane, incubated in 0.4N NaOH, neutralized with 1X TBS, baked at 80˚C for 
20 minutes, and blocked overnight at 65˚C in blocking buffer (4X SSPE, 6X Denhardt’s, 
300µg ml-1 salmon sperm DNA, 0.1% [w/v] SDS).  The blot was incubated with a 1:5000 
dilution of streptavidin conjugated alkaline phosphatase (Pierce) in blocking buffer for 20 
minutes at room temperature, washed 3 x 15 minutes in TBST, and visualized using 
BCIP/NBT solution (Sigma).  The developed blot was scanned and signal was quantified 
using NIH ImageJ software (http://rsb.info.nih.gov/ij/). 
Determination of Bmi1-dependent peaks of uH2A:   Peak enrichment calls were generated by 
the TIROE program (algorithm described in (Ho, Jothi et al. 2009)).  Briefly, input was set to 
the mapped tag BED file corresponding to wild-type ChIP-seq and with the Bmi1 null BED 
file set to background.  Parameter cut-offs were set as follows: p-value(p) ≤ 1e-5, Fold 
enrichment cutoff (f) ≥ 5, and Average DNA fragment length(f) of 232. 
Gene analysis groupings:  REFSEQ gene coordinates were extracted from the UCSC table 
browser and the list was parsed to only consider one isoform per annotated gene.  Isoform 
selection was carried out by first searching for the 3’ most transcription start sites.  If a single 
gene had more than one isoform sharing a single TSS, then the longest isoform was kept for 
analysis.  Promoters were defined as -1kb to +1kb surrounding TSSs and previously 
published peak data sets (Mikkelsen, Ku et al. 2007; Meissner, Mikkelsen et al. 2008) 
composed of H3K4me3, H3K27me3, CpG nucleotide density calls, and HCP promoter 
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methylation analyses were re-mapped onto this gene list.  High resolution mapping 
surrounding gene TSSs was accomplished by extracting per base pair Bmi1-dependent uH2A 
tag density reads at 200 bp intervals surrounding TSSs.   
Peak distribution analysis:  The location of TIROE uH2A peaks was carried out in relation 
to the alignable genome as previously defined (Mikkelsen, Ku et al. 2007).   
Standard Error calculation:  Whole genome averaging analysis error bars represent the 
standard error of the mean (s.e.m.) and P values were determined using student’s t tests.  
Two-sided proportional testing, Wilcoxon signed-rank testing, and box plot generation were 
carried out using the R package. 
  
 
Figure 4-1.  Bmi1-dependent promoter uH2A enrichment correlates with promoter 
H3K27me3 enrichment.  (A) Profiles of per base pair Bmi1-dependent uH2A enrichment 
across the TSS of well annotated genes.  Error bars represent s.e.m. of per base pair average 
for all genes analyzed (n=15867). (B) Well-annotated genes were grouped by epigenetic 
modification state and the average normalized uH2A tag density was determined for each 
group.  No K4/No K27 (n=4690), purple; both H3K4me3 and H3K27me3 (Bivalent) 
(n=1377), green; H3K27me3 only (n=888), blue; H3K4me3 only (n=8912), red; all genes 
(n=15867), grey. 
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Figure 4-2. Bmi1-dependent promoter uH2A enrichment at a sub-set of gene promoters.  (A) 
Bmi1-dependent tag density at selected gene promoters that contain peaks defined by the 
TIROE program.  Red arrow indicates the start and direction of transcription. (B) ChIP-
qPCR validation of uH2A peaks (blue bars) and Bmi1 enrichment (red bars) was carried out 
in WT and Bmi1 null MEF cells.  Enrichment was normalized to input control and data is 
presented as log2 value of WT versus Bmi1 null. 
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Figure 4-3.  Promoter and non-promoter peaks of Bmi1-dependent uH2A are distinct.  (A) 
Proportion of promoter uH2A peaks (n=671) (left bar) and non-promoter uH2A peaks 
(n=15735)(right bar) which overlap with H3K4/H3K27 methylation peaks.  No K4/No K27, 
purple; both H3K4me3 and H3K27me3 (Bivalent), green; H3K27me3 only, blue; H3K4me3 
only, red.  (B) Box plot representation of peak tag density distribution for promoter and non-
promoter uH2A peaks.  Red lines indicate median values.  P value derived from Wilcoxon 
signed-rank test.  (C) Box plot representation of peak tag density distribution for promoter 
(+) and non-promoter (-) uH2A peaks further sub-divided by H3K4me3/H3K27me3 co-
localization.  No K4/No K27, purple; both H3K4me3 and H3K27me3 (Bivalent), green; 
H3K27me3 only, blue; H3K4me3 only, red.  White lines indicate median values.  P value 
derived from Wilcoxon signed-rank test. 
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Figure 4-4.  uH2A deposition is linked to DNA methylation.  (A) Bmi1-dependent per base 
pair uH2A tag density was determined for genes defined as high CpG dinucleotide promoter 
content (HCP, blue) (n=10,310), intermediate CpG dinucleotide promoter content (ICP, red) 
(n=2889), low CpG dinucleotide promoter content (LCP, green) (n=2668).  (B) HCP class 
genes with available DNA methylation data were grouped based on the presence (+) (n=266) 
or absence (-) (n=8230) of a promoter bound peak of Bmi1-dependent uH2A and the 
distribution of DNA methylation values for each group was visualized using a standard box 
plot.  Red lines indicate median values.  P value derived from Wilcoxon signed-rank test.  
(C) Western blotting of uH2A was carried out using cell lysate prepared from wild-type and 
Dnmt1 null MEFs. H3 was used as a loading control.  (D) Cytosine extension analysis was 
carried out using wild-type and Bmi1 null MEFs as well as Dnmt1 null and control cells.  
Biotin labeled restriction digests were spotted in triplicate onto a Nylon membrane and 
visualized using alkaline phosphatase.  The procedure was repeated three independent times 
and data for one representative experiment is shown.  (E) Data presented in panel D were 
quantified and presented as the ratio between methylation sensitive HpaII incorporation 
versus methylation insensitive MspI incorporation.  Error bars represent s.e.m. (n=3). 
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Figure 4-5.  Bmi1-dependent uH2A is enriched at repressed genes.  (A) Bmi1-dependent 
uH2A tag density surrounding the TSSs of genes was calculated and grouped into 10 bins 
(n≈1335 for each group) based on de novo gene expression levels in MEF cells. (B) Bmi1-
dependent uH2A tag density was calculated for the region indicated in (A) for genes grouped 
based on de novo expression in MEF cells (n=4007, n=2674, n=2668, n=4005; highest 
expressed to lowest expressed).  Error bars represent the s.e.m. of the highest expressed and 
lowest expressed gene groups.  (C) WT MEF expression of genes with (+, n=483) and 
without (-, n=12,871) a peak of Bmi1-dependent uH2A was subjected to data distribution 
analysis by standard box plot.  Red lines indicate median values.  P value derived from 
Wilcoxon signed-rank test is indicated.  (D) Gene promoters with (+) and without (-) peaks 
of uH2A were analyzed for the presence of H3K4/H3K27 methylation peaks.  No K4/No 
K27, purple; both H3K4me3 and H3K27me3 (Bivalent), green; H3K27me3 only, blue; 
H3K4me3 only, red.  (E)  Box plot of expression data distribution for promoters with (+) and 
without (-) uH2A peaks in WT MEFs were further sub-divided by H3K4/H3K27 co-
localization.  No K4/No K27, purple; both H3K4me3 and H3K27me3 (Bivalent), green; 
H3K27me3 only, blue; H3K4me3 only, red.  White lines indicate median values.  P value 
derived from Wilcoxon signed-rank test is shown.  (F) Genes containing a peak of Bmi1-
dependent uH2A were divided into three groups based on increasing peak tag density 
(n=157, 157, and 158, respectively) and the distribution of log2 expression change (Bmi1 null 
versus WT MEF cells) was presented by box plot.  Red lines indicate median values.  P value 
derived from Wilcoxon signed-rank test is shown. 
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Figure S4-1.  Genic peak distribution analysis reveals peak number enrichment towards the 
transcription termination site of genes and peak tag density enrichment within gene 
promoters.  (A) Distribution histogram of peak location along the transcribed region of well-
annotated genes (TSS, transcription start site; TES, transcription end site).  (B) Genic uH2A 
peaks were grouped by their location within transcribed genes and the tag density data 
distribution was visualized by standard box plot.  Red lines indicate median values.  P value 
derived from Wilcoxon signed-rank test. *, **, and *** respectively indicate P value of 2.2e-
14, 1.1e-15, 2.6e-10. 
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Table 4-1.  Bmi1-dependent peak distribution throughout the mouse genome. 
 Genome* Peak 
P value** BP coverage Number BP coverage 
Gene & Promoter 893514855 (47.4%) 8086 (49.3%) 7748448 (52.4%) <2.2e-16 
Promoter 39206000 (2.1%) 671 (4.1%) 755102 (5.1%) <2.2e-16 
Transcribed Region 854308855 (45.3%) 7415 (45.2%) 6993346 (47.3%) <2.2e-16 
Non-genic 1770940233 (52.6%) 8320 (50.7%) 7046343 (47.6%) <2.2e-16 
Total 1884453825 (100%) 16406 (100%) 14794791 (100%)  
* Total base pairs refer to alignable portion of the genome. 
** Two-sided proportional test of Genome BP coverage as compared to Peak BP coverage.
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 Table 4-2.  ChIP-qPCR primers used in the experiments described in Chapter 4. 
Gene Forward Primer Reverse Primer 
Cebpa CAGGGCAGGAGGAAGATACA CACCTAAGTCCCTCCCCTCT 
B4galnt1 GGCGGATTTACGATCCAGT GACTCCGGGGCTTTGTAGAC 
Gfod2 GGATGGGTTAGGTTCAAGCA ACGGCATTGAGTACGAGGTC 
Zfp12 GTGCGCACTTCTGTTTGTGT AAAGCTGCGAGCGTAGAGAC 
Fgf6 CTGAAGCAGGCTTTGGTTTC ACCGCCCTTCTTGTTTTTCT 
Dcxr GAGCGCATACTCCTCCACTC TGTTGGACTTGAGGTGGTCA 
Iars GGAGCGTCTTCTCCTTCCTT TGCCATCCAACACCTACAAA 
Arpc3 ATTTCCCCCTTGTCATTTCC TCCATCAGGGAAGTGAGGTC 
Chmp2a AACCAAATTAGGCCCACACA GGTGCAAGCAATGGAAGAAT 
Mta2 TTCGTCTGGAGCTGAGCTTT TCCCACCCGGTACATGTTAG 
Hbb2 GCCCAGGCTTAAGACATTTGAG GAATTAGCTGCAAGGATAAGAACAGA 
Ppara GAGACCCTGGAGATGGTTGA GTGTGCTTGTGTGCATGTGA 
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